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ABSTRACT 
 
C-reactive protein (CRP) is a serum protein that binds to damaged membranes 
and initiates the complement immune response. Different forms of CRP are thought to 
alter how the body responds to inflammation and the degradation of foreign material. 
Despite knowing that a modified form of CRP(mCRP) binds to downstream protein 
binding partners better than the native pentameric form, the role of CRP conformation on 
lipid binding is yet unknown. In this work, three main assays were performed to 
characterize how conformation affects CRP-membrane interactions. The first assay 
utilized supported lipid bilayers that mimic the plasma membrane of apoptotic cells. The 
results show that CRP interactions vary with protein conformation, lipid composition, 
and membrane shape and that the mechanism by which CRP recognizes damaged 
membranes depends on the combination of all three. The second assay focused on CRP 
interactions with cellular membranes by using induced apoptosis in MES-SA cells to 
characterize how CRP recognizes damaged cellular membrane. Monitoring the 
disassociation of pCRP to mCRP on apoptotic cell membrane with a fluorescent RNA 
aptamer that specifically binds mCRP but not pCRP allowed for quantitative analysis. 
Thirdly, a fluorescence quenching assay was utilized to characterize CRP conformational 
states using 8-anilino-1-naphthalenesulfonic acid (ANS), a fluorescence probe that binds 
to the hydrophobic regions of a protein. The unfolding of CRP using different denaturants 




SDS with heat were used to perturb the pentameric state. All treatments give rise to a 
monomeric state in native PAGE experiments. As revealed by ANS fluorescence, 
treatment with 2.5M GndHCl, 3 or 6 M urea, or 0.01% SDS caused hydrophobic portions 
of CRP to be exposed. Based on this data, we conclude that the two forms of CRP studied 
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CHAPTER ONE: INTRODUCTION 
1.1 C- Reactive Protein (CRP) 
 Cardiovascular diseases (CVD) are one of the leading causes of death in the 
world. Annually about 16.7 million deaths are attributed to chronic inflammatory 
diseases of the arteries and atherosclerosis[1]. In the United States around 610,000 cases 
of myocardial infarction every year are attributed to atherosclerosis[1]. The mortality 
rates of CVD have been reduced by 33% in the last 20 years due to improvements in 
treatment and early prevention. However, the elevated rate of current incidence requires 
researchers to develop treatments that prevent CVD[1]. Clinically, C-reactive protein 
(CRP) is a good indicator and a risk factor for CVD[2], [3]. CRP has been shown to 
accumulate at sites of inflammation[2], [3] and an elevated level of CRP is linked to 
chronic inflammation and cardiovascular disease (CVD)[3]. CRP was discovered by 
Tillet and Francis over 80 years ago and initially named C-reactive substance due to its 
reactivity and ability to precipitate the C- polysaccharide of the pneumococcus cell 
wall[4]. The blood plasma level of CRP rises dramatically in response to infection, tissue 
injury, and inflammation. CRP is a plasma soluble protein and acts as a marker for the 
cardiovascular disease (CVD)[3]. CRP levels in serum increase significantly and rapidly 
to 1,000 fold during the first 24-48 hours in response to inflammation. In 2003, studies 
demonstrated that people with slightly elevated levels of CRP, in a range between 3 and 




CVD[5]. This view was later revised when CRP was considered a participant and 
mediator in the formation of lesions and atherosclerosis due to its inhibitory effect of 
nitric oxide production by endothelial cells. Quenching the releasing of NO leads to the 
stimulation of endothelial cell apoptosis and inhibition of angiogenesis[5]. Studying CRP, 
a mediator and participant in CVD, will lead to a better understanding of the mechanism 
of plaque formation in heart disease. 
 CRP is a pentameric protein belonging to the pentraxin family, and is composed 
of five identical subunits (protomers) associated noncovalentaly[6]. The crystal structure 
of CRP was solved in 1999 and is shown in Figure 1. The crystallographic data shows 
that each promoter has binding sites for two calcium ions and one binding site for 
phosphatidylcholine (PC) on the recognition face of CRP (face B). The major interaction 
between PC containing ligands and CRP bound calcium ions occurs via a phosphate 
oxygen group of PC. The opposite face (Face A) exhibits binding sites for C1q, Fc 
receptor (FcR)[7], integrins[8] and C4b- binding protein[9]. 
CRP exists in at least two different conformations with distinct bioactivities. 
Native pentameric CRP (pCRP) and modified CRP (mCRP) are the most well studied 
forms. Previous work by Potempa in 1983 suggests that human CRP has two distinct 
forms, one is a native CRP (110 kDa) bound to PC, and the other as free subunits (22.5 
kDa), which expresses a new epitope leading to different reactivity. mCRP binds to 
downstream binding partners, such as factor H, C1q and C4bp[10]. Five novel molecular 
forms of CRP in human plasma which are different from pCRP and mCRP have also 







Figure 1. CRP crystal structure.  
CRP is a pentameric protein binds one phosphocholine head group (grey/red structure in 
center of monomer) per monomer unit in a calcium dependent manner (Ca2+ is green, 
two per monomer). Image was taken from the protein data bank (PDB Identifier: 1B09), 
and the structure was solved by Devaraj, et.al.[11]. 
 
 The main functions of CRP are to control inflammation, stimulate the clearance of 
tissue components and damaged cells, and to recruit damaged cells for phagocytosis[4]. 




Streptococcus pneumonia infection in mice[12]. CRP is involved in the activation of the 
classical complement pathway through its binding to different ligands which leads to the 
killing of microorganisms and the protection of the host. Among the ligands that mCRP 
is able to bind to activate the classical complement cascade, C1q binding is one of the 
most significant functions of CRP. mCRP binds C1q, which activates the complement 
response, and also C4bp1 and factor H, both of which attenuate the immune response. 
The monomeric form of CRP leads to pro-inflammatory states by binding to integrin 
proteins on monocytic U937 cells[8].  
 By binding C1q as part of the classical complement pathway, CRP is involved 
with both the innate and adaptive immune system. CRP activates the classical 
complement cascade and promotes an anti-inflammatory response when it binds to an 
apoptotic cell surface, by increasing binding of C3b/bi and C1q[4]. CRP binding 
improves the phagocytosis of apoptotic cells by macrophages. CRP inhibits the 
alternative complement pathway by recruiting factor H to the cell surface which inhibits 
C5 convertase and prevents the formation of the membrane attack protein (MAC). 
Another important property of CRP is its binding to Fcγ receptors which leads to 
increasing phagocytosis and releasing of inflammatory cytokines[4].  
 Phosphatidylcholine (PC) is the most well described small molecule that CRP 
recognizes and binds to on the surface of damaged and apoptotic cells[2], [13]. The Kd for 
CRP-phosphorylcholine ineraction is 18µM[14]. It is not clear why CRP does not bind 
PC present on healthy cells. Past work has shown that lysophosphatidylcholine (lysoPC) 
and PC are recognized by CRP. Both of these lipid are common in damaged membranes, 




result of partial hydrolysis of phosphocholine by the enzymatic action of phospholipase 
and represents ≤ 3.0% of the phospholipids in a cellular membrane[15]. It has also been 
shown that certain phospholipases or membrane damage cause PC to become more 
exposed and accessible to CRP [4]. Others have shown that the incorporation of lysoPC 
in the natural lipid bilayer induces positive curvature[16], by causing a disturbance due to 
acyl chain mismatch[17], and promotes CRP binding in phosphatidylcholine vesicles[18]. 
Also, lysoPC has been shown to mediate the binding and dissociation of pCRP on the 
surface of Jurkat T cells[19].  
In addition to lysoPC, CRP shows binding activity to both oxidized LDL 
(OxLDL) and apoptotic cells by recognition of their phosphorylcholine moiety that 
becomes more exposed due to oxidation which leads to opsonizing them for 
macrophages.[13] Lipid oxidation leads to a conformational switch in the structure of 
phospholipids by making the fatty acid tail hydrophilic. This causes protrusion of 
oxidized fatty acids from hydrophobic moiety to an aqueous environment[20].  
Beyond phosphatidylcholine oxidation, membrane curvature has been shown to 
enhance the binding of CRP to damaged membranes[21]. CRP shows curvature 
dependent binding to lipoprotein particle mimics (LPP) with high binding to LPP with 
diameter ≤ 28 nm. This binding causes CRP to disassociate to mCRP which expose a new 
epitope for C1q binding[21]. We hypothesize that both lipid composition and membrane 
curvature are factors by which CRP forms recognize damaged membranes for clearance.  
 The mechanism by which CRP converts to other forms has been discussed by 
others. pCRP dissociates on lipid monolayers that consists of egg PC/lyso PC into 




pentameric structure and has a conformational rearrangement when it binds to an 
endothelial cell membrane, forming mCRP that deposits in the blood vessel walls[23]. 
Moreover, pCRP changes conformation and transforms to a modified form under acidic 
pH conditions that mimic the environment of the inflammation sites[24]. 
 
Figure 2. Conversion of pCRP. 
Illustration of pCRP conformational changes upon its binding to a cell surface. 
 
Beyond lipids, CRP also has well described protein binding abilities. CRP 
interacts with various complement proteins such as C4 binding protein and factor H 
which leads to the activation of the complement pathway through its binding to one 
molecule of C1q per two adjacent molecules of CRP bound to a ligand[9]. Research 
shows that mCRP which forms due to the disruption of the structure of pCRP using urea 
is able to bind factor H and C4BP. However, native pCRP did not bind. In addition to 




Two novel receptors for mCRP were discovered and their binding linked to the pro-
inflammatory action of mCRP binding to U937 cells. In contrast, pCRP showed less 
effective binding to these integrins, which was attributed to an increased steric hindrance 
due to size[8]. 
 Cholesterol has also been identified as a novel ligand for CRP. The presence of 
cholesterol binding domains within CRP suggests that the non-esterified cholesterol 
content on the LDL surface has a role in CRP binding to modified LDL.[25] CRP has 




 C1q is an early component of the classical complement pathway and is known to 
bind CRP. It is a well-recognized protein of the innate immune system[27]. C1q is a 460 
kDa protein formed from six hetero subunits with each unit containing collagen-like 
trimeric helical fibers. Each of these subunits ends with a C-terminal globular region 
which binds to the apoptotic cell surface. C1q participates in the maintenance of the 
immune tolerance via phagocytosis[28].  
Previous studies have shown that C1q recognizes and binds to the 
phosphatidylserine (PS) exposed on the surface of apoptotic cells through its globular 
region at an early stage of apoptosis and allows for efficient apoptotic cell clearance. The 
dissociation constant for the interaction of C1q globular regions with PS is 7x10-8 M. C1q 




pathway. The C1q globular region forms a complex with phosphoserine through the 
interaction with subunit C of the globular region[28].  
CRP binding to C1q has been showed to trigger the activation of the classical 
complement pathway. The binding site of C1q on CRP was defined by Agrawal in 2001. 
Research showed the Asp112 and Tyr175 residues are important for the C1q binding site 
located at the end of the open side of the cleft on the promoter on the pentameric face 
opposite to the PC binding site[29]. The dissociation constant for the interaction of C1q 
with pCRP was determined to be 1.45 nM[9]. 
 
1.3 Membrane Curvature 
Lipids and proteins are involved in membrane deformation and curvature. Thus, 
changes in the lipid composition can cause membrane curvature and influences the 
morphology of the membrane26. Lysophosphatidylcholine (LysoPC) tends to form an 
inverted cone shape and generates positive curvature upon its addition to the lipid 
bilayer12. LysoPC is produced as a result of phospholipid hydrolysis by the phospholipase 
enzyme A2 in position 2 of phosphoglycerides27. Cellular membranes have different 
compositions of lipid that vary throughout the cell. LysoPC is a naturally occurring 
detergent that accounts for ≤ 3% of the lipid bilayer. The outer leaflet of a eukaryotic 
plasma membrane is mainly composed of phosphatidylcholine (PC) which makes up 
more than 50% of the phospholipids. In contrast, the cytosolic leaflet of the membrane is 
enriched with phosphatidylserine (PS) and phosphatidylethanolamine (PE) 26. 
 The presence of lysoPC has long been known to enhance CRP binding to 




the incorporation of lysoPC to PC liposomes led to a change in the geometry of the lipid 
model and caused a mismatch in the lipid bilayer that makes PC head groups more 
exposed and accessible to CRP to bind[18]. Binding between CRP and lysoPC has an 
impact on atherosclerosis[30]. CRP complexed with lysoPC has been shown to restrain 
pro-atherogenic effects on macrophage cells which in turn may delay the atherosclerosis 
progression.  
Phospholipids with two saturated acyl chains exhibit a cylindrical shape, inducing 
no curvature. Cone shaped lipids form if the head group is significantly smaller than the 
acyl chain area and lead to the generation of negative curvature (concave) with a smaller 
surface area. This forces the head groups to be close together against electrostatic 
repulsion and cause steric hindrance12. This configuration is energetically unfavorable in 
biological systems and can be stabilized by changes in lipid composition and the presence 
of certain proteins at curved regions, which facilitate protein binding to accommodate 
membrane deformation. Phospholipids that have a smaller acyl chain area than the head 
group form an inverted cone shape and generate an area of positive curvature (convex) 
with packing defects in the positive face12. The density of the hydrophobic defects would 
increase as a result of membrane bending, and the increasing in the surface area of the 
positive face will cause the hydrophobic tails to be exposed to the aqueous environment 
which is an entropically unfavorable situation. Increasing the density of the defects leads 
to the recruitment of large densities of hydrophobic molecules, 27 such as lysolipids that 
have single tails to fill the gaps and stabilize the hydrophobic defects. Figure 3 illustrates 




Some proteins, including BAR domains and amphipathic helices, are known to 
bind to curved membranes. Extreme membrane curvature within the cell can occur in 
different structures such as the golgi, endoplasmic reticulum, microvilli and the plasma 
membrane26. Plasma membrane curvatures play a vital role in cellular function. 
 
 
Figure 3. Chemical structure of lipids and dye labeled lipid used in this work.  
A) POPC [31], B) lysoPC[32] , C) MB-DHPE[33]. 
 
 
Beyond lipids, proteins are also involved in membrane deformation generating 
positive and negative curvatures. Amphipathic helices that have one polar charged face 
and one hydrophobic face promote membrane curvature via asymmetric insertion into 




curvature. The hydrophobic face dips into the tail section of the bilayer while the polar 
face interacts with the polar head group of the membrane[34]. 
Another mechanism by which cells deform lipid membranes is through the use of 
proteins. Scaffolding by proteins that have a rigid structure is one of the mechanisms that 
influence membrane curvature. Common examples of these proteins are the dynamin 
family of proteins that bind to inositol lipids and constrain tubular shape in the 
membrane. BAR domain proteins and banana shaped dimer proteins are considered to be 
sensors for highly positive curvature. These proteins bind strongly to highly curved 
membranes due to an increase in the area of electrostatic interaction and a matching of 
the intrinsic curved area of the protein with the area of curved membrane. Another aspect 
of BAR proteins is their interesting interaction with the N-terminal of an amphipathic 
helix (N-BAR domains) which induce positive curvature upon their insertion into the 
lipid bilayer.  
 Due to the complexity of the biological cellular membrane, it is a challenge to 
study how the membrane curvature and lipid shape affect molecule binding. Moreover, it 
is difficult to separate the shape of the membrane from the chemical compositions within 
the cell. Therefore, different methods have been proposed to mimic cellular membranes. 
One of these established methods uses a single liposome curvature assay (SLiC) to study 
membrane curvature sensing of biomolecules25. In this assay, liposomes of different 
curvature were labeled using a fluorescent lipid and immobilized on a glass surface. The 
size of the liposomes was determined from the relative fluorescence. The protein of 
interest was labeled with a different fluorescent dye and the density of bound protein was 




microscopy. The advantages of using this assay is to exclude the ensemble averaging 
error which can arise when polydispersity exists. The major disadvantage is that the 
liposomes are isolated, so the bound molecule cannot undergo dynamic exchange along 
the surface as in the plasma membrane.  
 Another group used a wavy glass substrate with continuous positive and negative 
curvature26. The liposomes were deposited on the surface to form a supported lipid 
bilayer (SLB). The advantage of using this method is that it has a transition between the 
area of positive and negative curvature. One disadvantage is that this method requires two 
different processes to characterize the curvature and to visualize the bound protein which 
requires another method to correlate them. The main disadvantage is that the lacking of 
highly curved regions. Moreover, preparing the glass requires high temperature and using 
a prefabricated mold which makes changing the topology of the glass to be used in 
different experiments difficult.  
 To overcome these limitations, our lab has developed a cell membrane mimic 
biosensor which is done in a way that allows us to separately change the shape and 
chemical compositions[35]. This is one of the main advantages of the system since it is 
challenging to do that in the biological system. Also, the spatial resolution between the 
protein of interest and the sites of curvature can be achieved by using this biosensor. The 
sites of curvature in this model are separated, so the equilibrium dynamic between the flat 
region of the membrane and the sites of curvature was permitted which mimic the blebs 
surface in the cells. This will help us to understand how CRP recognizes apoptotic cells 




the CRP conversion to mCRP which in turn binds C1q and leads to the activation of the 
complement system. Moreover this assay will allow us to know if the membrane shape 
affects CRP function.  
 Briefly, the SLB was formed over fluorescent polystyrene nanoparticles 40 or 100 
nm diameter that were deposited upon a flat glass surface. Liposomes were prepared by 
probe sonicating lipid films and lipid bilayers were created when liposomes fused with 
the surface[35]. Figure 4 shows the biosensor with the regions of positive, negative, and 
no curvatures. Fluorescent nanoparticles with different radii are used to control the extent 
of curvature.  
 
Figure 4. Cell membrane mimic biosensor model.  
Lipid bilayer formed on the top of fluorescence nanoparticles showed regions of positive, 








 This dissertation is divided into five chapters. Chapter two describes 
Characterizing the membrane curvature assay and discuses in details the quantitative 
analysis methods and programs that we used to quantify the data. It also focuses on 
investigating how lipid compositions and CRP forms affects binding to curvature. 
Chapter three focuses on using cellular membrane to characterize CRP binding to 
apoptotic cells using MES-SA cells. Chapter four discusses using fluorescence assays to 












2.1 Conformational Changes in C-reactive Protein Affect Binding to Curved 
Membranes  
This Chapter details the preparation of the curved supported lipid bilayer (SLB) to 
investigate whether or not CRP preferentially binds to curved membrane. The SLB 
enables us to separately quantify how the lipid composition and membrane shape affects 
CRP recognition membrane. In addition, the different conformations of CRP (pCRP and 
mCRP) affecting its binding to curved membranes was characterized. Fluorescence 
recovery after photobleaching technique (FRAP) was also used to test the fluidity of the 
lipid to ensure that the SLB mimics the biological system.    
 It has been shown that the conformational changes in CRP affect protein-protein 
interactions, but little attention has been given to how protein conformational changes 
affect lipid binding. It is interesting to note that PC is the predominant lipid headgroup in 
the outer leaflet of cell membranes, yet CRP does not bind PC present on the surface of 
healthy cells. Beyond Ca2+, it is not clear what is needed for CRP to bind to lipid 
membranes. Past work has shown that lysoPC and oxidized PC are recognized by CRP. 
Both of these lipids are common in damaged membranes, like apoptotic cells, but less so 
in healthy cells. Others have shown using mimics of LDL that neither lysoPC nor oxPC 
are needed; instead, CRP can recognize PC when it is presented on very small (diameter 




recruit CRP; curved membranes bind more CRP. Modified CRP binds curvature, but the 
soluble pentameric CRP does not over the range of curvatures tested. 
2.2 Materials and Methods 
2.2.1 Supported Lipid Bilayer 
Lipid films in this study were prepared by using 1-palmitoyl-2-oleoyl-sn-glycero-
3-phosphocholine (POPC) (Avanti Polar Lipids, 850457C) as the main component. In 
addition lysoPC (Avanti Polar Lipids) and marina blue 1,2-Dihexadecanoyl-sn-Glycero-
3-Phosphoethanolamine (MB-DHPE) were used. The molar ratio of these components 
are varied as desired. 
Our lab has developed a supported lipid bilayer (SLB) membrane mimic as 
described previously[35].The SLB was formed over fluorescent, carboxylate-modified 
polystyrene nanoparticles (FluoSpheres, Life Technologies;40-100 nm diameter) or over 
a flat surface. The nanoparticles were first diluted to (1:1000) in deposition buffer and 
sonicated in a bath sonicator for 15 minutes. Then, the second dilution of the sonicated 
nanoparticles was made to a ratio of (30:700) before their deposition onto the 8 well plate 
(Lab-Tek® Chambered Borosilicate Coverglass System, Thermo Fisher). 100 µl of the 
diluted nanoparticles was added to each well and incubated for 30 minutes at room 
temperature. After deposition, the nanoparticle solution was removed from the plate prior 
adding the lipid. Lipid compositions consisted of PC, lysoPC, and MB-DHPE were 
dissolved in filtered chloroform and stored at 4 ⁰C. PC (85% or 98%), lysoPC (14% or 
3%), and MB-DHPE (1% or 2%) were combined as desired in batches with a total of 250 
nmol and then dried under vacuum overnight to remove the chloroform. Upon use, a vial 




CaCl2, 30mM PIPES, 140 mM NaCl pH 6.4) and was probe sonicated for 15 minutes. 
100 μL of sonicated lipid solution was deposited in an 8 well plate and incubated at 37 °C 
for 1 hour. 50 μg/mL CRP or 50 μg/mL mCRP were incubated with the lipid bilayer at 37 
°C for 2 hours. Primary anti-C-reactive protein (C6), mouse IgG monoclonal antibody 
(Santa Cruz Biotechnology) and secondary goat anti-mouse immunoglobulin G with 
Alexa 488 (Life Technologies). Primary and secondary antibodies were pre-incubated 
together in 1:1000 ratios for 30 minutes at room temperature. 100 μl of pre-incubated 
antibody solution was added to each well. Imaging was done on both total internal 
reflection fluorescence (TIRF) microscopy and laser scanning confocal microscopy.    
 
2.2.2 Preparation of mCRP 
Modified CRP (mCRP) was prepared by treating native pCRP with SDS diluted 
to 0.01% in HEPES buffer (30mM HEPES, 140mM NaCl, 2mM CaCl2, or 30mM 
HEPES, 140mM NaCl, 2mM CaCl2, pH 6.39) and heating it at 80⁰C for an hour. pCRP 
was diluted to a final concentration 100 µg/mL. The conformational state of CRP was 
determined by using native polyacrylamide gel electrophoresis due to the different 
properties of pCRP and mCRP including running differently on a gel.   
 
2.2.3 Image analysis of flat membranes 
To analyze the binding of CRP to the membrane, Image J was used to identify 
spots in the protein channel that were saturated. Then, MATLAB was used to find the 
average intensity of the image without including the saturated pixels or the pixels that had 





2.2.4 Location guided averaging analysis 
Computational analysis of the images was done using location guided averaging 
analysis procedure in MATLAB statistical software. To find locations of curvature 
marked by red fluorescent nanoparticles, spots-finding methods were used based on 
freeware designed from the methods of Crocker and Grier[36]. The MATLAB code for 
these are found on the website by Blair and Dufrense[37]. Only the spot finding portion 
of the code was used for this work. Location were excluded if they were 9 pixels of 
another location or within 12 pixels of the image edge. Square regions of 25 by 25 pixels 
were cropped from images of the nanoparticles channel which represents the curvature 
location. The same region of corresponding locations in the protein channel were also 
cropped yielding pairs of images. All the cropped regions in each channel were averaged 
using ImageJ software to obtain a single image of 25 by 25 pixels of all the stacks. From 
the pairs of images, we measured the distribution of 1) Pearson’s correlation coefficients 
and 2) intensity in the 5 pixels center minus a local background consisting of an annulus 
1 pixel wide with a diameter of 13 pixels (ΔF). From the average of the green cropped 
images, a radial average was calculated. This is done by averaging all pixels that are a 
specific distance from the center pixel. For example, there are 4 pixels that reside one 
pixel (124 nm) away from the center (green squares) and these are averaged to give the 
second data point. Four pixels that reside 175 nm from the center are averaged to give the 
third data point and so on. MATLAB code for the radial averaging function is available 




dF and radial plot measurements have been used by others to quantify the amount of the 
protein at region of interest[38], [39]. 
The Pearson correlation coefficient (PCC) is a well-established method to 
quantify the colocalization degree between two fluorophores from a pair of images. It has 
been used to map protein association with exocytic vesicles and endocytic structures[38], 
[39]. PCC has range from +1 to -1, where +1 denotes strong positive correlation, -1 
strong negative correlation, and 0 indicates the absence of relation. 
To calculate PCC, small regions (25x25 pixels) are extracted from the 
nanoparticle image (red) along with the corresponding regions from the proteins image 
(green). As a control, random positions are selected, cropped, and processed in the same 
way. Then, all images are first normalized by subtracting the average. A deviation from 
the average is a fluctuation. If the fluctuations in one color match the fluctuations in 
another color then that is a correlation. After subtraction, the green image was multiplied 
by the red (each pixel is individually multiplied) then the average of all 25 x 25 pixels 
was divided by the average intensity of individual images as shown in the following 
equation: 





   Equation 1 
 
 When comparing different sized curvatures the surface area difference of the lipid 
bilayer was corrected as follows: the structure of the curvature was estimated to contain 
two parts: 1) a cylinder with a height equal to the radius of curvature (ROC) and a 




on top. The amount of surface area normally present in a flat bilayer is equal to a circle 
with a radius equal to the ROC. The difference between the two is the increase in surface 
area due to the presence of curvature. For an ROC of 25 nm, the increase in surface area 
is 2-fold. For an ROC of 55 nm, the increase in surface area is 4.84-fold. This correction 
is performed in Figure 22, where different curvatures are directly compared. 
 
2.2.5 Confocal microscopy 
Laser scanning confocal microscopy is a powerful tool that illuminates a small 
region of specimen by utilizing a small pinhole aperture that allows just for the light 
comes from the area of interest to pass throw it and rejects the out of focus light. In this 
work, the Olympus FV 1000 laser scanning confocal microscopy was performed and a 
100x oil objective (2x zoom) such that one pixel was equal to 124 nm and with numerical 
aperture (NA= 1.4). Three channels, blue, red, and green were used to sequentially excite 
the DHPE-Marine Blue with 405 nm with an emission window from 42 5nm to 475 nm, 
red nanoparticles were excited with 594 nm with an emission window from 575nm to 675 
nm, and CRP with 488 nm diode laser with an emission window from 500 nm to 545 nm, 
respectively. The speed of the scan was 12.5us/pixel. 
 
2.2.6 TIRF Microscopy 
 Total internal reflection fluorescence microscopy (TIRF) is a method primarily 
used to illuminate the fluorophores that are very close to the adherent cell surface or 
coverslip sample within 100 nm with an exponentially decreases in the excitation 




to reducing the intensity of the fluorophores that away from the coverslip. Moreover, 
highlighting the events close to coverslip-sample interface. To achieve TIRF, the angle of 
incident ϴ must be larger than the critical angle ϴc as well as the refractive index of the 
glass n2 should be greater than the refractive index of the sample n1.  
 
2.2.7 Fluorescence recovery after photo bleaching (FRAP) 
Fluorescence recovery after photo bleaching is an optical technique intended to 
use for Characterizing lateral diffusion of lipids within a cellular membranes[41]. To 
mimic biological membrane, the supported lipid bilayers formed in our lab should be 
fluid. To examine that, a circular region of 125 pixels by 125 pixels (ROI) was bleached 
using laser beam at 100% with 405 nm wavelength by laser scanning confocal 
microscopy. The emission was detected from 425nm to 475nm. Three initial frames were 
imaged before the photo bleaching, seven frames were taken after bleaching the bleached, 
and the total of 40 frames were imaged to obtain the recovery. The frames were taken at 1 
frame per 0.5 s. The speed of the scan for imaged frames was 2 µs per pixel. To analyze 
FRAP images, Image J and GraphPad Prism were used.  
 The average intensity of the photo bleached area (ROI) for all images was 
corrected to the intensity of a region apart from ROI (reference area). The mean intensity 
of ROI measured in each experiment was normalized. The intensity of the first image was 
set to 1 since it has a highest value in image series. The lowest value was set to 0 which 






2.3 Results and Discussion 
The main goal of our work is to detect what recruits CRP to bind the lipid 
membrane and determine how the conformation of CRP affects binding. To do so, two 
factors were addressed, the lipid bilayer composition and the degree of the membrane 
curvature. The membrane curvature assay used in these experiments allows for control 
the composition of the bilayer independently from the bilayer curvature. First, we 
examined the effect of introducing lysoPC to the membrane containing POPC, which is a 
CRP binding site as shown in figures 4 and 5. Second, we tested the effect of membrane 
curvature on recruiting CRP.  
In order to mimic the biological system, it is very important for the SLB to be 
fluid. Therefore, the lipid fluidity was tested using FRAP technique before all the 
experiments were performed. 
 
2.3.1 Fluid lipid on a patterned substrate 
FRAP experiments were performed to measure the MB-DHPE percent recovery, 
diffusion constants, and mobile fraction on a flat surface or curved membrane (40nm, 
100nm nanoparticles). ImageJ was used to retrieve FRAP data as described previously in 
section 2.2.6. Briefly, a region with diameter (125x125 pixels) was bleached using 100% 
laser power. Then lipid recovery was obtained by measuring a total of 40 frames. 
After correcting for photobleaching as described above in method section, the 
following equation was used to fit the data to a curve.  
                   𝐹𝑡 = 𝐹0 + (𝐹∞ − 𝐹0) ∗ (1 − 𝑒





Ft, 0,  represents values of fluorescence at given time, initially, and equilibrium, 




                                        Equation 3 
 
The diffusion constant, D, is related to the square of radius, r, of the bleached 
area, the half time, 𝜏½, and a constant of the bleach shape, γD, as: 
                 𝐷 = (𝑟
2
4𝜏½
⁄ )𝛾𝐷                                                        Equation 4 
   
A representative FRAP series of MB-DHPE is illustrated in  





































Figure 5. Fluidity of lipids measured by FRAP technique. 
Series of MB-DHPE lipid FRAP images show intensity recovered in the bleached circle 
region in time. The bleach frame is at t=0.00s. The frame rate is 0.8 frame/sec. Images 
were corrected for overall photobleaching and the data was used to calculate lipid 
fluidity parameters (   Figure 6). 
 
FRAP was also used to test the fluidity of MB-DHPE on variety of curvature size 
using nanoparticles varied in diameter (45 nm, 100 nm), and a flat surface. The fluidity of 
MB-DHPE on POPC bilayers, POPC containing 3% of lyso PC bilayers, and on flat 
surface of POPC were tested.  The recovery, diffusion constant, and mobile fraction are 
shown in figures 6, 7.  Mobile fraction was obtained by dividing the average normalized 
intensities of the final three frames by the average intensities of the first three frames 
before photobleaching. 
 
            t= -3.75s  t=0.0s         t=1.25s  





   Figure 6. Lipid fluidity is measured by FRAP technique. 
  A) Average recovery of normalized intensity of lipid bilayers contains 98% POPC, 2%     
MB-DHPE are shown for 100 nm, 45 nm, and flat. The data shows the fit of 5, 3, and 3 
experiments collected for 100 nm PC, 45 nm PC, and flat PC membranes respectively.   
B) Average recovery of normalized intensity of lipid contains 95%POPC, 3%lysoPC, 2% 
MB-DHPE are shown for100nm, 45nm. The data shows the fit of 4, and 4 experiments 
collected for 100nm PC/lysoPC, and 45nm PC/lysoPC membranes respectively. 
 
 
FRAP data of the various recoveries of different lipid mixtures on either flat or 
curved surfaces is shown in    Figure 6. Unpaired t-test revealed no significant differences 
between the recoveries over a curved surface with 100 nm and a flat surface (p = 0.1656) 
figure 6 A and between the two curved surfaces (100 nm, 45 nm) (p=0.1491). The 
recoveries of lipid bilayers containing 98% of POPC over a flat surface was significantly 
higher as compared with curved membranes with 40 nm diameter (p = 0.0054) figure 6 
A. The recoveries of lipid bilayers contain 95% of POPC, 3% lysoPC over curved 












































Figure 7. Lipid diffusion and mobility. 
A) Comparing lipid fraction are not significantly different between the groups (p>0.05 
ANOVA). Error bars represents SEM. B) Diffusion coefficient are not significantly 
different between the groups (p>0.05 ANOVA).Data represents the average of 5, 
3,3,4,and 4 experiments collected for 100 nm PC, 45 nm PC, flat PC, 100 nm PC/lysoPC, 




The fluidity of different surfaces was not significantly affected by changing the 
lipid composition and size of curvature. No significant statistical difference in diffusion 
constant, and in mobile fraction were obtained between the groups (P-value > 0.05 
ANOVA) (Figure 7). Comparison of mobile fraction and diffusion constant between flat 
membrane and curved membrane is illustrated in Table 1. 
 
Table 1. Comparison of Diffusion constant and mobile fraction between different lipid 
bilayer 
 





      w/ 100 nm NPs 
0.566 ±  0.073 0.729 ± 0.037 
POPC bilayer 
      w/ 45 nm NPs 
0.594 ± 0.230 0.681 ± 0.046 
POPC w/lysoPC bilayer 
     w/100 nm NPs 
0.638 ± 0.027 0.768 ± 0.032 
POPC w/lysoPC bilayer 
    w/45 nm NPs 
0.516 ± 0.084 0.812 ±0.05 
 POPC bilayer w/o NPs 0.549 ± 0.046 0.849 ± 0.07 
 
2.3.2 Influence of lipid type on CRP binding to a flat membrane 
To test the effect of lipid type on CRP binding, pCRP or mCRP were incubated 




BSA was used as a negative control. Briefly, mCRP was prepared in our lab as described 
previously[42] by incubation of pCRP with final concentration of 0.01% SDS at 80 ⁰C for 
one hour. The final concentration of pCRP was 50 µg/ml. mCRP runs as a monomer on a 
native polyacrylamide (supplement figure 1). 
 
 
Figure 8. Influence of lipid type on CRP binding. 
Fluorescent images of BSA (A), pCRP (B), and mCRP (C) binding to supported lipid 
bilayers contains 98% POPC and 2% MB-DHPE. CRP is labeled with primary D7 






























Figure 9. Average intensity of CRP binds to flat membrane. 
 Average intensity of BSA, pCRP, or mCRP binding to flat bilayers contains 98% POPC 
and 2% MB-DHPE. N=24, 29, 19 images for mCRP, pCRP, and BSA respectively, 3 
experimental days. Back ground intensity was not subtracted. Error bar is SEM. 
Statistical significance was observed (p<0.05) between pCRP, mCRP, and between 
pCRP, BSA.  
 
Confocal images showed that the flat SLB membrane with POPC recruited pCRP slightly 
less as compared with mCRP Figure 8B, C. Quantification of the image intensity using 
MATLAB revealed that there is no significant difference for pCRP and BSA binding to 
the flat membrane, while mCRP binds significantly more than pCRP and BSA with 






2.3.3 Incorporating lysoPC into flat lipid bilayer enhances pCRP binding 
 Since previous studies have indicated that the PC liposomes that contain lysoPC 
enhanced CRP binding[43], we sought to test the effect of introducing lysoPC to the lipid 
bilayer on the recruitment of CRP.  The influence of introducing lysoPC at 14% to the 
lipid bilayer containing 85% of POPC and 1% of MB-DHPE on CRP binding is shown in 
Figure 10. Images acquired by using TIRF revealed an increase in CRP binding to the flat 
membrane with lysoPC. 
 












Figure 10. The effect of addition of lysoPC to POPC flat membrane on pCRP binding. 
A) TIRF images showing CRP binding to A) flat membrane contains 98% of POPC and 































Figure 11. Average intensity of CRP binding to a flat membrane contains lysoPC. 
 Average intensity of CRP binding to POPC or POPC-lysoPC flat membrane with the 
intensity of the antibody subtracted. N=12 images, 2 experimental days. CRP monoclonal 
mouse antibody C6 was used. No significant statistical difference was detected 
(p=0.299). The error is the SEM. Computational analysis was also performed to quantify 
the effect of lysoPC on CRP binding  
 
 
Figure 11. MATLAB was used to find the spots for both images and detect their 
intensity. The intensity of saturated pixels which represents the cluster of the antibody 
molecules was not included in the total average intensity of each image. 
TIRF images and the statistical data reveal that the membrane containing lysoPC 
recruits 50% more of CRP than the membrane that contains only POPC on flat 
membranes. The average intensity of the background was subtracted from the average 
intensity of CRP binding to both lipid membranes. Future work should be done to give a 




This finding is in agreement with previous work that showed incorporation of 
lysoPC to PC vesicles promoted CRP binding[18]. This is also relevant to a previous 
observation that showed association of CRP in vivo with membrane of altered or necrotic 
cells but not with the healthy cells[44] . This can be interpreted due to the restriction 
accessibility of polar PC head group to the water phase in intact membrane of healthy 
cells and not been freely accessible to CRP to bind. This is supported by NMR data that 
revealed the presence of intramolecular interaction between PC polar head group in 
artificial PC bilayers[45]. Therefore, it was suggested by Volanakis that binding of CRP 
to the PC polar head group in intact membrane requires disturbance in the bilayer 
geometry. This was tested by incorporating of lysoPC to PC bilayer which enhance CRP 
binding due to the relaxation effect that lysoPC cause to the restriction of accessibility of 
PC head group[18]. LysoPC is a single tail lipid tends to form an inverted cone shape and 
creates positive curvature. 
 Beyond assessing the effect of the flat membrane on CRP binding, we sought to 
determine whether curved membranes enhance CRP interactions with lipids using our 
membrane curvature assay described in Chapter 1.The following section illustrates in 
details the techniques that used to analyze the data. 
 
2.3.4 Quantitative analysis of curved supported lipid bilayers 
To determine whether or not CRP preferentially bound to curved membranes, 
supported lipid bilayers were created over a nano-patterned surface as described in 
methods section. Briefly, fluorescent nanoparticles were deposited at a density of 0.01-




labeled with green fluorescent antibodies. Two color, confocal imaging was performed to 
determine whether or not CRP bound to curved membranes. The red fluorescent 
nanoparticles mark locations of membrane curvature (Figure 12A), as demonstrated in 
previous work[35].The green fluorescent channel relates the amount and location of CRP 
(Figure 12B). The lipid bilayer is composed of MB-DHPE (2%) and POPC (98%), a 
common lipid on the cell surface, with regions of curvature that have a radius of 
curvature (ROC) of 55 nm.  
To quantify imaging data, nanoparticles were identified using a spot finding 
algorithm as described in method section. Nanoparticles that were separated by more than 
9 pixels from other nanoparticles and more than 12 pixels from the edge of the images 
were cropped to 3.1 µm x 3.1 µm (25 x 25 pixel) images. The same locations were 
cropped from the CRP channel and three examples of single cropped images are shown in 
Figure 12C. The average of the nanoparticle images shows a spot in the center, as 
expected. The average of the CRP images also contains a spot, but when random 
locations are selected or BSA is used instead of CRP, no spot is detected (Figure 12C). 
This object-based method of data analysis yields pairs of images that can be further 
analyzed to obtain distribution information or averaged to obtain bulk information. 
Because nanoparticles are very bright relative to the background and 
monodisperse in both size and intensity, it is straightforward to automate the 
identification of curved membrane locations. This is less true of CRP images. The 
variability in protein number yields a wider range of intensities and a more subjective 
measurement if spots were counted from this channel first. The identification of regions 




guided colocalization methods[35], [38], [39]. From individual pairs of images the 
Pearson correlation function was calculated to relate how similar the two images are, with 
-1 being images that are opposites and +1 being identical. The distribution of correlation 
values is plotted as a histogram Figure 12 D and very little is observed to be correlated in 
samples containing pCRP and curved POPC bilayers, Figure 12 D, black bars. Random 
















Figure 12. Description of the quantitative analysis of curved supported lipid bilayers. 
Supported lipid bilayers were created on a surface containing red fluorescent 
nanoparticles then imaged after incubation with CRP.  A) Red fluorescent nanoparticles 
images mark sites of curvature. B) Green fluorescently labeled protein (pCRP) is imaged 
separately. Red positions are located using spot finding algorithms and positions are 
shown with circles. C) The positions that are > 13 pixels from the image edge and >9 
pixels from another position are cropped to a 25 x 25 pixel region, where one pixel = 124 
nm. The cropped locations are labeled with magenta circles 1-6.  The same locations are 
cropped from the green image, shown in yellow circles 1-6, yielding pairs of images. 
Random positions are selected and cropped as a control D) The Pearson’s correlation 
coefficient is calculated for image pairs and a histogram of all pairs of images is plotted 
for pCRP at regions of curvature (black) and pCRP at random positions (magenta 





The correlation function is useful for colocalization measurements, but the 
intensity information is lost so we performed another measurements that retain 
information related to the amount of protein present at curvature. All cropped, green 
(CRP) images (n=3297) were averaged and a radial plot of the intensity as a function of 





















Figure 13. Radial plot calculation. 
 A radial plot of the average images is calculated in MATLAB by averaging all pixels that 
are a certain distance from the center pixel (shown in magenta). There are 4 pixels that 
reside one pixel (124 nm) away from the center (green box), and these are averaged to 
give the second data point (green arrow). Four pixels that reside 175 nm from the 
center (blue box) are averaged to give the data point shown beside the blue arrow and so 
on. The height of this plot at 0 nm is related to the amount of protein bound to 
nanoparticle positions. The offset at distances far from the center is related to the amount 
of protein that binds flat membranes, more than 1 µm away from curvature. The 
difference between the height and the offset, is related to how well the protein senses 
curvature relative to flat membranes. Background intensity was subtracted using the 
average intensity of the tail from the CRP monoclonal C6 antibody radial plot. The error 





This is done by averaging all pixels that are the same distance from the center, as 
described in the figure caption and methods. After subtracting the background intensity, 
the intensity of samples lacking green fluorophores, there are two pieces of information 
in this plot: the height and the offset. The height is a measure of the amount of 
fluorescence at regions of curvature and the offset is a measure of the fluorescence due to 
binding to flat membranes. This method of analysis and these three measurements are 
used to quantify how the lipid composition, protein conformation and membrane shape 
separately affect CRP recognition of membranes.  
 
2.3.5 CRP conformation affects binding to curved membrane 
It is well known that the conformation of CRP affects binding to downstream  
proteins, such as C1q and Factor H [3]. Here we tested whether CRP conformation 
affects lipid binding to both curved and flat regions of membrane. Supported lipid 
bilayers containing 98% POPC and 2% MB-DHPE were created over top of a fluorescent 
nanoparticle patterned surface (ROC = 55 nm) then incubated with CRP and CRP 
antibodies. The modified form of CRP (mCRP) was made as previously described. In this 
preparation, the tertiary structure remains intact as demonstrated by the ability of mCRP 
to bind downstream partners of the complement immune response in a way that acid 
treated or fully denatured CRP does not[42].  Visually, mCRP shows high colocalization 
to nanoparticles sites and is also present in flat regions when compared to pCRP Figure 
14A. The average of the cropped, nanoparticle images shows a spot in the center, as 




identically and linearly for direct comparison. A spot appears in the center for mCRP, 
pCRP, samples with no CRP (and only antibodies, termed “none”), but not for samples 
where the surface has been blocked with BSA instead of CRP or when random regions 
are chosen instead of nanoparticle regions.  
To assess the interaction between CRP conformers and curved membranes 
further, correlation coefficients were calculated from pairs of cropped images Figure 
14B. mCRP (black bars) and pCRP (grey line) are different; mCRP has a higher 
correlation to the nanoparticle positions, suggesting higher preference for curvature. The 
average correlation coefficient is 0.29 for mCRP (Figure 14) and this is due to a large 
diverse distribution (Figure 14B). pCRP has an average of 0.03, which is similar to 
samples where no CRP has been deposited and antibodies alone accumulate at curved 
membranes. Randomly chosen positions show near 0 correlation. The data are illustrated 
in table 2. 
 
positions Cavg STDEV SEM n 
Curvature 0.29 0.26 0.004 3792 
Curvature 0.03 0.14 0.002 3297 
Curvature 0.04 0.16 0.004 1413 
Random 0.0005 0.08 0.0024 1100 
 









Figure 14. Protein conformational effects 
Modified CRP and native, pCRP conformations of CRP are prepared and incubated on 
curved supported lipid bilayers, then imaged using confocal microscopy. A) Average 
images of nanoparticles, mCRP, pCRP, samples with antibodies only (“none”), and BSA 
blocked samples with antibodies only have been cropped from regions selected from 
nanoparticle positions. Random positions were also selected and mCRP regions were 
cropped from random positions (labeled “random”). The images are all scaled linearly 
and identically. B) The distribution of correlation coefficients for pairs of cropped 
images is measured for mCRP (black) and pCRP (dashed line). C) The average of the 
distribution is plotted for mCRP, pCRP, images with antibodies alone (no CRP), and 
CRP at random regions instead of curved membrane regions.  
  
 
Modified CRP accumulates at curvature and the amount and distribution is 
quantified by plotting the radial distribution from an average image (Figure 15). The 









Figure 15. Comparing the Radial average intensity of CRP conformers at ROC (55nm). 
From the average images, the intensity is averaged radially to show the accumulation of 
mCRP and pCRP in both flat (large distance and curved (small distance) regions. 
Background intensity was subtracted using the average intensity of the tail from the CRP 
monoclonal C6 antibody radial plot. The error is the SEM 
 
 
The increase in fluorescence at curvature relative to background, ΔF, is calculated 
from the height – offset for each cropped image, where the height is a pixel-weighted 
average of the first two points in the radial curve. The offset is measured 6 pixels away 
from the center, a distance greater than the spread of the intensity in the center but less 
than the nearest neighbor distance. In Figure 16, the average of all cropped images is 



















Figure 16. Average intensity of CRP conformers at sites of curvature. 
The preference for curvature over flat regions, ΔF, is calculated from radial plots and the 
average of the distribution is shown. In all bar graphs, the error is the SEM. 
 
The mCRP form was able to bind membranes significantly more than the pCRP 
form. This is likely due to hydrophobic regions of CRP being exposed once the pentamer 
is broken apart. Hydrophobic proteins preferentially insert into membranes or aggregate. 
In our work, we observe membrane incorporation and this membrane incorporation does 
not require Ca+2. It is likely that any protein with hydrophobic parts exposed would show 
binding to curvature. Intrinsically disordered proteins were recently discovered to induce 




membranes[46]. To determine if this is a universal occurrence for any disordered, 
anchored, or denatured protein requires further experimentation.  
Figure 14 reveals that mCRP readily binds curved membranes, much more so 
than pCRP, which hardly binds at all. Regions of curved membranes are thought to differ 
from flat regions in the way that lipids are packed. Curved regions have defect sites – 
sites where there is more space between headgroups than tails – which are thought to 
allow exposure of the hydrophobic tails to the surrounding aqueous solution. Defect sites 
are places on a membrane where protein and lipids can accumulate if there is a need for 
hydrophobic interactions. Modified CRP, which is stabilized by SDS, likely has 
hydrophobic portions exposed. Research demonstrates that mCRP likes to aggregate[47] 
which usually occurs through hydrophobic interactions. Here, hydrophobic regions could 
be stabilized by binding to defect sites, as observed by the high binding of mCRP, but not 
pCRP to curvatures of 100 nm.  
 
2.3.6 Lysophosphatidylcholine (lysoPC) increases CRP binding to curved membranes 
The presence of lysoPC has long been known to enhance CRP binding to 
damaged cell surfaces or on the surfaces of liposomes[48] . To investigate how changes 
in the chemical composition affect CRP binding, supported lipid bilayers that contained 
3% lysoPC, 2% MB-DHPE (to measure fluidity) and 95% POPC were created over a 
nanopatterned surface where both flat and curved membrane regions were measured 
simultaneously. Upon the addition of lysoPC, the Pearson’s correlation coefficient 
increased for both pCRP and mCRP Figure 17 A, B. In both cases, there is an increase in 




shown relative to random positions and a dashed line indicates the position without 
lysoPC. There is an increase by approximately 0.1 for both forms of CRP suggesting the 

























Figure 17. Lipid composition effects 
CRP was incubated with lysoPC containing membranes (LysoPC:POPC:MB-DHPE at 
3:95:2 molar ratio) that had regions of curvature (ROC = 55 nm). CRP (m and p 
conformers) were incubated with the bilayers for one hour at 37°C and then imaged. 
Images were cropped about nanoparticle positions and random positions and 
quantification is described in Figure 12. From cropped images, the Pearson’s 
correlation coefficient was calculated for A) pCRP (black bars) and B) mCRP (black 
bars). The grey line in both plots denotes the distribution of the correlation coefficient in 
membranes that do not contain lysoPC. C) The average value of the distribution with 







To determine how much CRP accumulates at nanoparticle regions when lysoPC is 
present, the intensity of CRP fluorescence is quantified .The height of the radial plot of 
mCRP increases slightly as shown in Figure 18, where the black line is the radial plot 
without lysoPC and the black circles are with lysoPC. The height of the radial plot of 
pCRP at nanoparticles increases more, from 97 counts to 438 counts, where the grey line 
is the radial plot of pCRP without lysoPC and the open circles depict the radial plot in the 
presence of lysoPC.  
 
 
Figure 18. Radial averages of mCRP and pCRP binding to sites of curvature. 
 mCRP and pCRP binding to lysoPC bilayers (red circles and blue circles, respectively), 
mCRP (black dashed line) and pCRP (green dashed line) on bilayers without lysoPC. 
The purple solid line is from random positions. Background intensity was subtracted 
using the average intensity of the tail from the CRP monoclonal C6 antibody radial plot. 








The increase of fluorescence at nanoparticle sites (ΔF) also shows that pCRP 
binding is affected by the presence of lysoPC as shown in Figure 19. Both the pCRP and 
the mCRP changes are statistically significant (P <0.05), indicating that lysoPC serves to 
increase binding of all forms of CRP to curved regions more so than to flat regions, but 















Figure 19. The average of the ΔF distribution. 
ΔF for mCRP and pCRP with and without lysoPC at ROC 55nm. , ΔF, is calculated from 







The data indicated that the lipid composition also affects binding to both curved 
and flat membranes. LysoPC is a marker for damaged membranes and the interaction 
between CRP and lysoPC was first identified in the 1970s[18]. One advantage of the 
experimental configuration is the ease at which lipid composition can be altered 
separately from the membrane shape. In Figure 17, we show that lysoPC enhances 
binding more at curved regions than on flat regions and enhances both pCRP and mCRP 
binding. This is likely due to the accumulation of single tailed lipids at sites of 
curvature[35]; there is a higher density of lysoPC at the curved regions to bind CRP. 
Others have suggested that lysoPC introduces irregularities into artificial lipid 
bilayers[18]and that these are essential to binding pCRP. The presence of lysoPC affects 
pCRP more than mCRP, increasing the accumulation by 4-fold as opposed to a 10% 
increase at curved membranes Figure 19, suggesting that mCRP associates in a way that 
does not depend significantly on binding lysoPC, whereas pCRP association does. pCRP 
likely interacts through headgroup interactions as others have observed on highly curved 
membranes lacking lysoPC[21]. 
 
2.3.7 Membrane shape affects CRP binding 
The shape of a membrane has been shown to affect protein binding for a variety 
of membrane associated proteins, such as BAR domains[49], amphipathic helices[50], 
[51], and lipid –anchored proteins[46], [52]. By decreasing the size of nanoparticles used 






Figure 20 shows how the Pearson’s correlation coefficient distribution is affected by 
membrane shape for both conformations. The distribution shifted to higher, more 
colocalized coefficients for pCRP Figure 20A, whereas the shift was to lower coefficients 
for mCRP Figure 20B. In both figures the correlation coefficient between larger 
nanoparticles and CRP is shown as a magenta curve and the correlation coefficient 































Figure 20. Membrane curvature effects: 
CRP recruitment to curvature with a smaller nanoparticle support (d = 45 nm, ROC = 
27 nm) was measured using confocal microscopy. Lipid bilayers contained 98% POPC, 
2% MB-DHPE A) The Pearson’s correlation coefficient distribution for pCRP and 
nanoparticle images, depicting the higher curvature (ROC = 25 nm, black bars) and 
lower curvature (ROC = 55 nm, magenta curve) normalized correlation coefficient 
distribution for 1574 and 3297 nanoparticle positions, respectively.  B) The Pearson’s 
correlation coefficient distribution for mCRP and nanoparticle images, depicting the 
higher curvature (ROC = 27 nm, black bars) and lower curvature (ROC = 55 nm, 
magenta curve) normalized correlation coefficient distribution for 1368 and 3792 
nanoparticle positions, respectively.  
 
 
The results were similar when 3% lysoPC was included in the bilayer Figure 21. 




pCRP associates with higher curvatures better. The mechanism by which mCRP and 




Figure 21. CRP recruitment to curvature: 
CRP recruitment to curvature with a smaller nanoparticle support (d = 45 nm, ROC = 
25 nm) was measured using confocal microscopy. Lipid bilayers contained 95% POPC, 
3% LysoPC, 2% MB-DHPE A) The Pearson’s correlation coefficient distribution for 
pCRP and nanoparticle images, depicting the higher curvature (ROC = 25 nm, black 
bars) and lower curvature (ROC = 55 nm, magenta curve) normalized correlation 
coefficient distribution.  B) The Pearson’s correlation coefficient distribution for mCRP 
and nanoparticle images, depicting the higher curvature (ROC = 27 nm, black bars) and 




One key difference in the membranes that are formed over large nanoparticles (lower 
curvatures) compared to smaller nanoparticles (higher curvatures) is the surface area. 
When projected onto a 2D image, the larger nanoparticles contain 4.84 times the amount 
of surface area than a flat region and the smaller nanoparticles contain 2 times the amount 
of surface area (see Materials and Methods for the explanation). It is relatively 
straightforward to correct for the surface area differences when measuring intensity  
Figure 22. The intensity (y-axis) was corrected for surface area by dividing by 
either 4.84 for low curvature membranes or 2 for high curvature membranes. After 




areas (ΔFSA), mCRP collects at larger nanoparticles (lower curvature) at a density greater 
than the accumulation at smaller nanoparticles (higher curvature). However, pCRP shows 
the opposite trend, in agreement with the work of others[21]. The shape of a membrane 








Figure 22. The preference for curvature over flat regions (ΔFSA). 
ΔFSA is calculated from radial plots (not shown) and normalized for differences in 
surface area. The mean +/- SEM are plotted for all lipid, curvature and CRP 
conformation. To correct for surface area differences, the values for higher curvature 
were divided by two and the values for lower curvature were divided by 4.84 to compare 
the protein density at curvature to that at flat regions. Grey columns correspond to 
mCRP, white columns are pCRP. Striped columns contain no lysoPC, whereas the solid 
columns contain 3% lysoPC. Antibodies used for these experiments were CRP 
monoclonal C6 and CRP monoclonal D7 for curvatures with radii of 55 nm and 27 nm, 
respectively. A supplemental figure with dot blots for these antibodies can be found in the 
appendix. 
 
The native form of CRP (pCRP) binds at a higher density to higher curvatures 
than to lower curvatures both in the presence of lysoPC and without lysoPC in Figure 22. 
This is in agreement with past work on CRP[21] and other proteins, such as 
palmitoylated proteins[46], [52] and amphipathic helices[50]. In previous work on CRP, 
very high curvatures (ROC = 10-15 nm) were tested and shown to bind pCRP better than 
lower curvatures (ROC = 20-35 nm), however the lower curvatures likely bound pCRP to 
a lesser extent based on the fact that CRP was activated in some way to be able to bind 




C1q after incubation[21]. All binding was Ca2+-dependent, indicating that the pCRP:PC 
interaction was likely through binding of the PC moiety as opposed to an interaction with 
the lipid tails.  Curvature could enhance binding by facilitating multivalent 
interactions[53] .To support this mechanism, recent work measured CRP binding 
constants on an engineered surface where the distance between PC ligands was 
varied[54]. In this work, the dissociation constant decreases by approximately 25-50% 
when PC is separated by 1.0-2.0 molecules/nm2, a distance larger than the natural 
packing of lipids on a flat membranes[55].Once PC groups are too far apart for 
multivalent binding (>2.0 molecules/nm2), the dissociation constant increases again. 
Regions of curved membranes are thought to differ from flat regions in the way that 
lipids are packed and curving a bilayer would results in a larger spacing between lipid 
head groups, also known as defect sites. 
At lower curvatures (ROC = 55 nm) mCRP bound membranes significantly more 
than pCRP. Other proteins, such as amphipathic helices, preferentially insert into curved 
membranes through hydrophobic interactions with the defect sites that occur as a lipid 
membrane bends around a curved surface [52]. Curved regions have defect sites, which 
are thought to allow exposure of the hydrophobic tails to the surrounding aqueous 
solution and potentially interact with hydrophobic proteins.  
Defect site binding to membranes, alone, cannot explain the clear preference mCRP has 
for larger curvatures  
Figure 22. One mechanism by which a specific shape preference comes about is 
from a 3D protein structure that has an intrinsic curvature, like a BAR domain[49] or a 




shape to their intrinsic curvature. It is possible that mCRP could form larger aggregates 
on membranes, as others have proposed[47], giving rise to a larger structure that has a 
specific curvature preference. We see no direct evidence of aggregation in our assay. A 
second mechanism for specific curvature sensing could arise from multivalent binding. 
Recent work shows that CRP binds with different affinities based on the separation of PC 
headgroups[54].  For a protein to detect curvature in this way would depend on retaining 
some multimeric state.  It is possible that higher order structures are what drive CRP 
binding and this structures form better on membranes with a radius of curvature of 55 nm 
as opposed to 25 nm. In the future, a wider spectrum of sizes could be studied to further 
understand CRP binding. 
 
2.4 Conclusion 
In this Chapter, a nanopatterned substrate was utilized to introduce curvature into 
continuous lipid bilayers for quantitative image analysis of CRP binding. One major 
advantage of this assay is the ability to separately tune chemical composition and 
membrane shape[35]. This work demonstrates that the conformational state of CRP 
affects lipid binding. Monomeric CRP readily associates with membranes, favoring sites 
of curvature over flat regions. Native, pCRP does not easily associate with membranes 
until the curvature is high (ROC = 25 nm) or until lysoPC is introduced.  CRP likely 
recognizes damaged lipidic materials through a mechanism that combines PC binding by 
pCRP and membrane insertion into defect sites, which stabilizes mCRP. Both of these 









3.1 CRP recognition of apoptotic cellular membranes 
CRP is known to bind to apoptotic cells to facilitate their clearance[56], and this 
activity prevents autoimmune disease[57]. To do this, a possible conversion takes place 
between two isoforms – pentameric CRP and modified CRP. This conversion affects CRP 
binding to C1q, an established recognition protein of the innate immune system. However, 
the triggers that cause pentameric CRP (pCRP) to convert to the modified form (mCRP) 
upon binding to apoptotic cells is still not well understood[7],[19]. Moreover, the factors 
that allow CRP to recognize and bind PC in apoptotic cells selectively compared to healthy 
cells need to be established. Since both healthy and apoptotic cells have PC on their outer 
leaflet, it is probable that another factor that helps CRP bind to apoptotic cells. There are 
several differences between apoptotic and healthy cells. First, the physical structure of the 
cell membrane varies as the apoptotic cells form cellular blebs (curved protrusions) during 
apoptosis. Second, the distribution of  lipid compositions between the inner and outer 
leaflet of cell membrane is changed since the phosphatidylserine (PS) flip to the outer 
leaflet during apoptosis[58].   
We hypothesize that once CRP binds to the surface of apoptotic cells 
conformational changes can take place that activate CRP-C1q binding. To test our 




For our in vivo work, we used MES-SA cells, a human uterus sarcoma cell line, to 
induce apoptosis using the drugs valinomycin and paclitaxel. After treatment, we measured 
the binding of CRP using fluorescence microscopy. The cells membrane was visualized 
using Annexin V, which binds to the phosphatidylserine present on the extracellular side 
of the apoptotic membranes, and large blebs were identified by their shape. This work 
included three stages, one where we measured whether or not CRP binds more to apoptotic 
cells. Secondly, the binding of the C1q protein to apoptotic cells and the 
immunofluorescence of C1q with CRP on apoptotic cells were measured. The research has 
also advanced to examine the conversion of CRP from pentameric to monomeric form after 
incubation with apoptotic cells for different amounts of time by utilizing a RNA aptamer 
that specifically binds to mCRP but not pCRP[42], [59]. 
 
3.1.1 Apoptosis 
Apoptosis is programmed cell death accompanied by morphological changes such 
as cell shrinkage, chromatin condensation, and plasma membrane blebbing. Later, these 
blebs separate from the dying cells as apoptotic bodies with their membranes intact and 
then they are engulfed by macrophages[60]. Apoptosis differs from necrosis since necrotic 
cells do not form blebs, and do lose their membrane integrity. This process starts with the 
cytoplasm swelling and ends with cell lysis when cells release their intracellular 
components that stimulate inflammation[61]. 
 Another important feature of apoptosis is the flipping PS to the outer leaflet of the 
plasma membrane, which is considered as a recognition ligand for neighboring cells. This 




these cells with no release to their constituents leads to no inflammatory response[60]. 
Also, apoptotic cells can stimulate phagocytes to produce anti-inflammatory cytokines.  
The mechanism by which PS translocate to the outer leaflet of the membrane is not 
completely understood. Lipid asymmetry under normal conditions is maintained by the 
activity of flippases and floppases between the outer and inner leaflet. However, during 
apoptosis scramblase becomes activated which leads to loss lipid asymmetry and causes 
PS to expose to the outer leaflet.  Apotosis can also be detected by some proteins such as 
AnnexinV which is shown to be exposed on the surface of apoptotic cells. Annexin V, is a 
specific protein binds strongly to PS and helps to detect apoptosis[58]. 
 In addition to PS flipping to the plasma membrane outer leaflet, the lipid 
compositions of this outer leaflet also undergo specific changes during apoptosis. It has 
been shown that the lipid order of the outer leaflet significantly changes during apoptosis. 
The loss of lipid order has been connected with lipid scrambling and sphingomyelin (SM) 
hydrolysis which cause SM to flux from outer to inner leaflet[62]. Apoptosis is initiated 
through complicated, regulated machinery by activating Caspases, proteins degradation 
enzymes.  
 
3.1.2 Drugs used for Apoptosis 
In this study, two different drugs, valinomycin and paclitaxel were used to induce 
apoptosis. The first, valinomycin is a selective membrane transporter protein for potassium 
ion K+ across the cell membranes. It is a cyclic antibiotic consists of 12 carbonyl groups 
allows it to bind to metal ions and solvates in a polar environment. Valinomycin captures 




responsible for its solvation in non-polar environment. Therefore, in the membrane lipid 
phase valinomycin complexed with K+ can be transferred into the other side of the cell[63].  
It has been reported that valinomycin triggers mitochondrial permeability transition causes 
intracellular acidification which activates cysteine active site protease causes degradation 
of the nuclear proteins and chromatin condensation[64] 
 
3.1.3 Paclitaxel (Taxol) 
 Paclitaxel is a chemotherapy drug that binds tubulin and protects microtubulin from 
being disassembled by stabilizing them, and blocks G2/M phase in cell cycle[65]. The 
mechanism by which Taxol induces apoptosis is still not very clear. It has been reported 
that Taxol induced massive apoptosis in MCF7cells[66]. Taxol has been shown to 
modulate the phosphorylation of some molecules and cycles in MCF7 cells that are 
involved in apoptosis and cell proliferation. The significant elevation in the activities of 
these molecules, ERK and p38 MAPK in cells treated with Taxol, leads to the suggestion 
that these molecules mediated Taxol induced apoptosis in MCF7 cells. Previous studies  
reported that ERK promotes apoptosis by inducing the release of cytochrome C which 
enhances the activation of Caspases involved in apoptosis[67].     
 
3.1.4 CRP binds to apoptotic cells and converts to mCRP 
 CRP has been shown to bind to apoptotic cells and consequently enhances the 
activation of the classical complement pathway. It also promotes their opsonization and 
phagocytosis by macrophages[56]. CRP could target many molecules on the surface of 




shown the binding of CRP to the membranes of cells or liposome will result in a rapid but 
partial structural change of pCRP producing a hybrid molecule, membrane bound 
molecule (mCRPm), and that retains a pentameric conformation with partial structural 
changes[19].  mCRPm binds to C1q and leads to complement activation.   
Research suggests that mCRP has a proinflamatory effect since it was bound to 
membranes in atherosclerotic plaques,  however healthy vessels have neither form of 
CRP [6]. mCRP- HAECs interaction was mediated by mCRP insertion to the 
membrane[68]. The nature of this binding was evaluated by washing the cells with high 
salt, acid, or base to dissociate electrostatic adsorption, high affinity receptor binding, or 
peripheral protein from cell membrane, respectively. mCRP interaction with HAECs was 
not affected by any of these treatments. This indicated that mCRP binding was receptor 
independent and likely driven by lipid interactions.   
mCRP has been shown to bind to lipid raft microdomains in human aortic 
endothelial cells (HAECs) with a binding affinity 20x more than pCRP[68]. This 
interaction was mediated by mCRP membrane insertion instead of receptor binding using 
the putative cholesterol binding sequence of CRP (aa 35-47) and the C-terminal 
octapeptide (aa 199-206). This was characterized by pre incubation of mCRP with 3H12, 
antibody that recognizes (aa 199-206) or with 8C10, antibody that recognizes (aa22-45) 
which contains cholesterol recognition domain. Then mCRP complexed with the 
antibody was injected under monolayer contains egg PC/cholesterol/SM (3:1:1) or egg 
PC monolayer that does not contain cholesterol. Results from pressure measurements 
indicate that mCRP complexed with 3H12 decreases binding of mCRP to the monolayer 




 In addition to the proinflamatory effect, mCRP has showed to play dual role in 
activation and inhibition of the classical complement pathway. mCRP binds to C1q, the 
initiator of the classical complement pathway, on the damaged human cells surface and 
necrotic heart tissue. This leads to trigger the activation of the complement pathway and 
allows opsonization with C3b. C4bp, a regulator and classical pathway inhibitor, and 
factor H, the alternative pathway inhibitor, were recruited to the damaged cells surfaces 
by mCRP which leads to block the complement cascade progression and inhibit the 
inflammation[69].  
 
3.2 Material and Methods 
3.2.1 Induction of apoptosis and CRP incubation 
MES-SA cells were grown at 37°C / 5% CO2 in McCoy’s media supplemented 
with 10% fetal calf serum, 100 μg/mL penicillin, and 100 μg/mL streptomycin. Cells 
were incubated in DMSO or 100 μM valinomycin for 4 hrs. Hoechst 387 DAPI nuclear 
stain was added to the cells and allowed to incubate for 5 minutes at 37⁰C. Then, cells 
was incubated with Annexin V Alexa594 stain for 15 minutes at 37⁰C. Cells were fixed 
by using 4% formaldehyde for 15 minutes and then washed 3 times with phosphate 
buffered saline PBS buffer. Human CRP was purified from endotoxin by using 
Endotoxin Removal Gel. 20 μg/mL CRP was added to both fixed control and apoptotic 
cells and allowed to incubate for 45 minutes in the presence of Tris buffer with 1 mg/mL 
BSA. Primary anti-CRP (C8), mouse IgG monoclonal (1:100000) (Santa Cruz) was 
incubated for 20 minutes, then secondary goat anti-mouse immunoglobulin G with 




Images were taken using an Olympus laser scanning confocal microscope. The 
membrane of each individual cell was highlighted using free hand tool, then the intensity 
of CRP was calculated by using this equation:  
𝐶𝑅𝑃 𝐼𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 = 𝐶𝑅𝑃 𝐼𝑛𝑡𝑒𝑔𝑟𝑎𝑡𝑒𝑑 𝐷𝑒𝑛𝑠𝑖𝑡𝑦 𝑜𝑓 𝐶𝑒𝑙𝑙 𝐴𝑟𝑒𝑎 −
 (𝑀𝑒𝑎𝑛 𝐵𝑎𝑐𝑘𝑔𝑟𝑜𝑢𝑛𝑑 𝐼𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 × 𝐶𝑒𝑙𝑙 𝐴𝑟𝑒𝑎)     Equation 5 
 
3.2.2 Induction of apoptosis and C1q incubation 
 100 μM valinomycin dissolved in DMSO was used to induce apoptosis in MES-
SA cells for 4 hours. Control cells were exposed to an equal concentration of DMSO 
(1:1000). Cells are then stained with cell mask in PBS buffer followed by the addition of 
10 μg/mL Hoechst DAPI nuclear stain (Invitrogen), and incubated for 5 minutes at 37⁰C. 
Cells were washed by PBS, and fixed by incubation with 4.0% formaldehyde for an hour 
followed by washing three times with PBS. The apoptotic and control fixed cells were 
incubated with C1q (10 μg/mL) for 30 minutes at 4⁰C. C1q was visualized using a 
primary mouse monoclonal anti-C1q (ab714940) antibody and a secondary rabbit anti-
mouse IgG Alexa 488 with a 1:1000 dilution. 
 
3.2.3 Induction of apoptosis by using paclitaxel  
Paclitaxel was diluted with DMSO to final concentrations of 700 nM or 900 nM. 
Cells were incubated for 16 hours, and then stained with DAPI and annexin V Alexa594. 
Control cells were exposed to DMSO with a final dilution (7:10,000) or (9: 10,000). Live 





3.2.4 Aptamer detection of CRP conversion  
MES-SA cells were incubated in 900 nM of paclitaxel for 16 hours. Afterward, 
cells were washed 3 times with PBS buffer. 10 µg/mL of CRP or 10 µg/mL of mCRP 
were added to apoptotic cells which had been plated in different wells at varying 
incubation times. Protein incubation was done with Tris buffer with 1% BSA to block 
nonspecific binding. mCRP was prepared by heating pCRP with 0.01% SDS at 80⁰C for 
an hour. A RNA aptamer specific for mCRP (Integrated DNA Technologies, Coralville, 
IA) and end labeled with Cy3 was reconstituted with DEPC treated water and stored at -
20⁰C until use. The RNA sequence was 5′-Cy3-GCC UGU AAG GUG GUC GGU GUG 
GCG AGU GUG UUA GGA GAG AUU GC- 3′. Next, cells were washed with PBS to 
remove unbound proteins and then stained with DAPI stain followed by a 30 minute 
incubation with the aptamer at room temperature. Finally, cells were washed with PBS 
before imaging by confocal microscopy. Images were analyzed using ImageJ as shown in 
Figure 27. 
 
3.3 Determining incubation time for apoptosis  
3.3.1 Visualization apoptotic MES-SA cells using Annexin V 
 Annexin V Alexa 594 is a protein that has high affinity to bind to 
phosphatidylserine that flips to the outer leaflet of the plasma membrane upon 
programmed cell death. This assay allows to visualize the membrane of the apoptotic 
cells, blebs and quantify the percentage of apoptosis. Cells treated with 900 nM paclitaxel 
overnight show higher binding to Annexin V Alexa 594 than cells incubated with 700 nM 




the percentage of apoptosis of the cells incubated with 900 nM paclitaxel was 
27.0%±4.24 (SEM) as compared with the 700 nM apoptotic cells which was 21.4%±3.37 
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Figure 23. Annexin V Alexa 594 binds to apoptotic cells. 
Annexin V Alexa 594 binds to phosphatidylserine (PS) in live apoptotic cells (red). A) 
Fluorescent images of annexin V binding to cells after treatment with paclitaxel 
overnight. B) Percentage of apoptosis was measured by counting the cells that positively 
stained with Annexin V. N=453 and 500 cells for control groups treated with 700nM and 
900nM, respectively. For Paclitaxel groups, N=557 and 406 cells for cells treated with 






3.3.2 CRP binding to apoptotic cells 
After exposing MES-SA cells to valinomycin, quantitative measurements of CRP 
binding to the cellular membrane was done using ImageJ. The free hand tool in image J 
was used to highlight the outline of the cells’ membranes and to measure the intensity of 
CRP binding to each individual cell. Blebs of various curvatures can be seen in the 
apoptotic cell. The percentage of the apoptotic cells was 30% as compared to the control 
cells which was 6%. This was calculated by counting the cells that were stained by 
Annexin V Alexa594. Using image J and a set of images, the average intensity of the 
CRP binding the control cells was measured to be (2,798) with the standard error (252.1). 
For the apoptotic cells, the average intensity was (4,089) and the standard error was 






















Figure 24. CRP binds to apoptotic fixed MES-SA cells. 
A.) Control Cells treated with DMSO. B) Cells after incubating with Valinomycin for 
4hours. C) Apoptotic cell with blebs. Cells were stained with Annexin V that binds PS on 
the outer leaflet of the cell membrane. Primary anti-CRP (C8), mouse IgG monoclonal 
was used. Images were taken using confocal microscopy.  Image C was taken by Kathryn 
































Figure 25. Intensity of CRP binding to control and apoptotic cells. 
 Average integrated Intensity of CRP binding to control and apoptotic cells. The antibody 
background integrated intensity and areas of images that have no cells were subtracted 
and calculated using (Eqn. 3). N= 103, 170 cells for control and apoptotic cells 
respectively. No statistical significance was observed between control and apoptotic cells 
using t-test. p=0.136. 
 
 
3.3.3 C1q binding to apoptotic cells 
C1q, an early component of the classical complement pathway, has been shown to 
bind to apoptotic cells and enhance their clearance by inducing the activation of the 
complement pathway[27]. Our goal is to characterize the interaction between apoptotic 
cells and C1q, and to quantitatively measure C1q binding to the apoptotic cells.  C1q was 
incubated for 30 minutes at 4⁰C after staining the cells with DAPI stain and then fixing 




antibodies. Images were acquired using confocal microscopy. Condensed apoptotic 
nuclei were visualized using DAPI nuclear stain, a commonly used assay to assess 
nuclear morphology[70]. Annexin V was not used to check for apoptosis due to its 
binding affinity to PS, which can compete for C1q binding. Area of each nucleus was 
obtained using the threshold tool in ImageJ to highlight the nucleus. The average from 3 
days was used. The membrane of each individual cell was highlighted, and then the 
intensity of C1q was obtained using ImageJ and the (Eqn. 3) listed above. 
 
Figure 26. C1q binds to fixed apoptotic MES-SA cells. 
The integrated intensity of C1q binding reflects the mean ± SE of three experiments. N= 
47, 53, 44 cells for non-treated cells, cells treated with DMSO, and valinomycin 
respectively. The intensity of the background for each image was subtracted. Statistical 
significance was observed (P=0.022) between the average area of nuclei of cells treated 
with DMSO, and apoptotic cells. The average area of nuclei of cells treated with neither 
DMSO nor valinomycin was significantly less than average area of apoptotic cells 
(P=0.008). No statistical significance was observed of the average C1q intensity between 





Cells treated with valinomycin are shown to decrease in the area of the nuclei as 
compared to the cells exposed to DMSO or cells treated with neither valinomycin nor 
DMSO. The average area of apoptotic cells’ nuclei, DMSO treated cells ‘nuclei, or the 
nuclei of cells not exposed to DMSO or valinomycin are 83.60±4.30, 112.44 ±5.28, and 
128.46 ±7.98 respectively. The fluorescence integrated intensity of C1q increases when 
cells were apoptotic.  
Quantitatively, the average intensity of C1q bound to apoptotic cells is 114497.80 
± 14516.46 whereas the cells treated with DMSO have less C1q bound to them as 
reflected by the fluorescence average intensity which is 95986.25 ± 11497.00. Untreated 
cells have less C1q bound to them with an average fluorescence intensity 77747.39 ± 
1211.79.  
 
3.3. Aptamer binds to apoptotic cells incubated with pCRP and mCRP over time  
pCRP loses its pentameric structure and undergoes conformational rearrangement 
when it binds to endothelial cell membrane, forming mCRP that deposits in the blood 
vessel walls[23]. Our lab recently identified a RNA aptamer that binds specifically to 
mCRP but not pCRP[42]. In this research, aptamer was utilized to investigate whether the 
membrane of apoptotic cells can induce CRP conformational change. To follow the 
conversion from pentameric to monomeric form, CRP was incubated with the MES-SA 
apoptotic cells with different incubation time. The average intensity of aptamer binding 




each individual cell was highlighted, then the intensity of aptamer was calculated by 
using this equation:  
𝐴𝑝𝑡𝑎𝑚𝑒𝑟 𝐼𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 = 𝐴𝑝𝑡𝑎𝑚𝑒𝑟 𝐼𝑛𝑡𝑒𝑔𝑟𝑎𝑡𝑒𝑑 𝐷𝑒𝑛𝑠𝑖𝑡𝑦 𝑜𝑓 𝐶𝑒𝑙𝑙 𝐴𝑟𝑒𝑎 −
 (𝑀𝑒𝑎𝑛 𝐵𝑎𝑐𝑘𝑔𝑟𝑜𝑢𝑛𝑑 𝐼𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 × 𝐶𝑒𝑙𝑙 𝐴𝑟𝑒𝑎)     Equation 6 
 
 
The results show high aptamer binding intensity with the cells incubated with mCRP, 
while the cells incubated with pCRP show less binding (Table 1). Also, the results 
indicate higher intensity of aptamer binding to the cells incubated for two hours with 































                                    
























Figure 27. Aptamer binds to apoptotic cells at different time incubation. 
A) Aptamer binds to apoptotic cells after incubating with mCRP for 2h, B) pCRP for 2h. 
C) Average integrated density of aptamer binds to apoptoic cells at varying incubation 
time with the antibody background intensity subtracted. Error bar is SEM. N=248,337 
and 281, 364 for pCRP and mCRP at 2hrs, 1hr respectively. Statistical significance was 




Due to the significant role of CRP and C1q in removing apoptotic cells and 
activating the complement system pathway, we aimed to quantitatively assess the binding 
of these proteins to apoptotic cells. The results revealed that CRP preferred to bind to 
apoptotic cells compared to control cells. Previous studies have confirmed colocalization 
of CRP on the apoptotic cell surface[19].  
 We also investigated whether the membrane of apoptotic cells induce pCRP 




pCRP was utilized in this study to follow the pCRP conversion to mCRP on the surface 
of apoptotic cells membranes. The average intensity of aptamer that bound to cells 
incubated with mCRP was significantly higher (p<0.0001) than cells incubated with 
pCRP for two hours and one hour. Also, cells incubated with pCRP for two hours have 
showed significant aptamer binding than cells incubated with pCRP for one hour 
(p<0.0001). These data indicate that during two hours of incubation, more pCRP 
molecules dissociate to mCRP upon binding to the membrane of the apoptotic cells. Our 
finding is in agreement with previous work that showed the rapid dissociation of pCRP 
on the surface of apoptotic Jurkat T cells after 30 minutes of incubation by using mCRP 
mAB 3H12[19].  
To further confirm our finding, future work can measure tryptophan fluorescence 
of CRP after varied incubation time with apoptotic cells by using the supernatant to 
detect conversion of pCRP to mCRP. However, separation would be extremely 
challenging. Due to CVD relevance, future work can focus on using Human Aortic 
Endothelial Cells (HAEC) to investigate if conditions for pCRP conversion is cell type 
specific or universal. Since previous studies suggested that binding pCRP to apoptotic 
cells is mediated by lysoPC[56], fluorescently tagged lysoPC and CRP can be used for 











4.1 Using fluorescence binding assays to characterize CRP conformational changes 
4.1.1 Protein denaturation 
Proteins in their native states have three dimensional folding structures known as 
secondary, tertiary, and quaternary structure. The proper function of a protein relies on its 
native form. Exposing a protein to any factor such as organic solvents, acids, bases and 
heat leads to the protein losing its native form and ability to perform its biological 
activity, and to protein denaturation. On the cellular level, denaturation of a protein 
causes disruption in the biological activity and cell death. Denaturation of proteins causes 
major changes in original native form of proteins without altering their primary 
structures. It is well-known that the structure of a protein dictates its function. 
Urea is a well-known denaturant shown to destabilize the native structure of a 
protein. Two mechanisms have been proposed to interpret the denaturation effect of urea, 
a direct and an indirect mechanism. Direct mechanism is when urea interacts with 
hydrophobic side chains, polar side chains or with the backbone. Indirect mechanism is 
when urea changes the water properties to a solvent which causes protein denaturation. It 
has been shown that van- der Waals interactions between the hydrophobic solute and 
solvent is more attractive in urea due to an enthalpic driving force[71],[72]. This is 
explained by the large dipole moments and the high polarizability of urea. Calorimetric 




decreases the enthalpic and the entropy of unfolded proteins, which in turn decreases the 
Gibbs free energy of unfolding proteins and promotes protein unfolding[73].  
 Guanidine-HCl is a widely used denaturant that destabilizes the native states of 
macromolecules. It is a chaotropic agent that disrupts a non-covalent forces such as 
Vander Waals interaction, hydrogen bonding and hydrophobic effects. 
Experimental contributions from Carrie Moon in this chapter include gel electrophoresis, 
tryptophan fluorescence, and ELISA. 
 
4.1.2 Fluorescence binding assay of 8-anilino-1-naphthalenesulfonic acid (ANS) 
To monitor CRP unfolding after incubation with different denaturants, 1-
Anilinonaphthalene-8-sulfonic Acid (ANS), a hydrophobic fluorescent probe was 
utilized. ANS has been used frequently in biochemistry and biophysics research to study 
protein folding and aggregation. ANS has polarity due to its negative charge on the 
sulphonated naphthalene group and due to the amide group electrons in the aniline ring 
that form hydrogen bonds with the proteins. 
 It also has hydrophobicity due to its aniline ring and 
naphthalene backbone. ANS aromatic rings help to 
stabilize its binding with apolar regions of 
proteins[74]. 
 ANS binds to hydrophobic regions of protein 
noncovalently which leads to significant increase in 
quantum yield. The orientation of the two naphthyl groups 
of ANS becomes oriented in parallel upon binding to the 
Figure 28. 1-
Anilinonaphthalene-8-





hydrophobic domains of the protein; this causes a significant increase in ANS 
intensity[75]. When the protein exposes more of its hydrophobic region, the binding 
events with ANS increase, which in turn causes an increase in the fluorescence intensity 
accompanied by blue shift. If the protein is fully denaturated, the ANS binding will 
become unstable and easily detach and become free in solution. Due to the loss of the 
organized structure of the fully denatured proteins, there is no longer a complimentary 
structure between the hydrophobic region and charged region, so ANS can just form one 
kind of interaction with the protein. In this case, the fluorescence intensity of ANS will 
become low as compared to partially denaturated proteins[74]. Possible fluorescence 
spectra of ANS is shown in  
 
 
Figure 29. Possible ANS fluorescence spectra. 
























4.1.3 Tryptophan fluorescence assay 
 Tryptophan fluorescence is a widely used assay to monitor conformational 
changes of proteins. The maximum emission  wavelength and the fluorescence intensity 
of tryptophan (Trp) are sensitive to the polarity of its local environment which makes it a 
good indicator for structural changes of proteins[76]. Trp fluorescence decreases and 
shifts to red with a longer wavelength when the Trp residue is exposed to an aqueous 
environment. pCRP contains 30 residues of Trp. The TRP residue location are 67, 100, 
110, 162, 188, and 205 as shown in Figure 30. Inter subunit involves the 115-123 loop of 






Figure 30. CRP amino acid sequence. 
Tryptophans are found as residues 67, 100, 110, 162, 188, and 205.Image was taken from 






4.2 Material and Methods 
4.2.1 Modified Native PAGE 
 CRP forms were visualized using a modified Native Polyacrylamide Gel 
Electrophoresis system (PAGE)[42]. Standard Laemmli conditions were followed with 
the exception of using 0.005% SDS in the gel and using a native loading buffer (no SDS, 
BME, or heat). 0.43 μg of CRP was loaded in each well. Gels were run at 80 V for 2 
hours and then silver stained. Bio-RAD precision plus protein standards ladder was used. 
 
4.2.2 Tryptophan Fluorescence 
 Tryptophan Fluorescence of CRP was read using a Tecan Infinite M1000 plate 
reader with samples in Corning black half-area 96 well plates (product #3694). 
Measurements were made with an excitation wavelength of 280nm. The integral from the 
emission spectra from 300-400nm was used for comparing fluorescence intensity, and 
then each value was normalized to the average pCRP integrated intensity. 
 The standard buffer used in the experiments was 30 mM HEPES, 2 mM CaCl2, 
140 mM NaCl (chemicals purchased from Thermo-Fisher or Sigma Life Sciences unless 
otherwise noted). Purified human CRP (Academy Bio-medical Company #30P-CRP110) 
was used as pCRP when diluted with the standard buffer. CRP concentration per sample 
was 57.5 μg/mL. Each denaturant used for converting pCRP to mCRP was made in the 
standard buffer mentioned above. Stock solutions of 8 M urea, 10 mM EDTA and 6 M 
guanidine hydrochloride were made in the standard buffer and used for dilutions. Urea 




temperature prior to analysis. mCRP was also made with 0.01% SDS in standard buffer 
and heated for 1 hour at 80-85°C[42]. 
 
4.2.3 Binding assay of 1-Anilinonaphthalene-8-sulfonic Acid (ANS)  
ANS, a hydrophobic fluorescent probe (Cayman chemical) was used to monitor 
the conformational changes of CRP after treating the protein with different denaturants. 
The stock solution of ANS was made using dimethyl sulfoxide (DMSO), and diluted to a 
final concentration of 200 μM by using Millipore water. Guanidine hydrochloride (2.5M, 
5.7M), Urea-EDTA (3M, 6M) and HEPES buffer containing 2 mM CaCl2, 140 mM NaCl 
with pH value 6.4 was used. CRP (50μg/ml) was incubated with the denaturants for 2 
hours at 37°C.Then, ANS was added to the black polystyrol half area 96 well plate (Life 
Science). The fluorescence intensity of ANS was measured in a spectrofluorometer 
(Infinity M1000) by using an excitation wavelength of 390 nm, and an emission 
wavelength from 440 nm to 650nm. Tryptophan fluorescence measurements were also 
done before and after adding ANS to the plate. 
 
4.3.3 Enzyme Linked Immunosorbent Assay (ELISA) 
The binding of CRP to C1q was measured by performing an ELISA with C1q as a 
capture at a concentration of 1 µg/mL, following previously published procedures[42]. 
Bovine serum albumin (BSA, 1 µg/mL) was used as a control in place of the C1q 
capture. BSA and C1q were diluted in coating buffer (30 mM sodium carbonate, 70 mM 
sodium bicarbonate, pH 9.6, Sigma Aldrich). 100 µL of coating solution was added to the 




655081). After a 2 hour incubation at 37 °C, wells were washed three times with 300 µL 
of phosphate buffered saline with 0.05% Tween-20 (PBST; Acros Organics) and once 
with 300 µL of phosphate buffered saline (PBS, pH 7.4). This was followed by tapping 
the plate dry on a stack of paper towels and Kimwipes. Next, 300 µL of blocking buffer 
(3% w/v BSA in PBST) was added and the plate was incubated at room temperature for 2 
hours. In between each step in the assay, wells were washed as described above (300 µL 
in each well, 3 times with PBST and once with PBS) and then tapped dry on paper 
towels. 100 µL of CRP (1.8 µg/mL) in diluting buffer (1% w/v BSA in PBS) was added 
and incubated for 1 hour at 37 °C. The primary antibody, a biotinylated polyclonal anti-
CRP was diluted at a ratio of 1:5,000 in diluting buffer and 100 µL was added and 
incubated for 1 hour at 37 °C. After washing, 100 µL of a 1:10,000 dilution of 
streptavidin-HRP (FROM?) was added to each well and incubated for 30 minutes at 37 
°C. A final wash sequence was followed by the addition of 100 µL of 3, 3’, 5, 5’-
tetramethylbenzidine (TMB) substrate. After the color was allowed to develop (5-10 min) 
at room temperature, the reaction was stopped by the addition of 100 µL of 0.5 M 
sulfuric acid, turning the reaction solution from blue to yellow. Absorbance was 
measured at 450 nm, with a reference absorbance of 620 nm on a Microplate reader 










4.3 Results and Discussion 
4.3.1 Denaturing CRP reveals metastable states 
To determine the stability of the native, pentameric form of CRP, we denatured 
CRP using two common denaturants, Urea with EDTA and GndHCl. The intrinsic, 
tryptophan fluorescence was measured and decreased with increasing denaturant, as 
expected, for most concentrations (Figure 31A and B). The change in fluorescence occurs 
as some of the 6 Trp residues (per monomer of CRP) go from a hydrophobic, protein 
environment to a more aqueous environment, where the fluorescence is substantially less. 
Denaturation with GndHCl led to a clear transition (Figure 31A) between 2.0 and 2.5 M 
GndHCl, however, the gradual decline in fluorescence from 0 to 2 M suggests 
conformational changes are occurring even at low concentration. CRP denatures quite 
easily but does not denature fully, as determine by comparing the fluorescence at 5M 
GndHCl to that of free Trp of the same concentration (Figure 30A).  
After measuring the intrinsic fluorescence to identify changes in the exposure of 
Trp residues to aqueous environment, samples were loaded onto a native gel to assess the 
presence of different states of CRP.  In Figure 31C, D, a clear transition occurs where a 
modified form of CRP begins to show up, running similar to the 20 kDa standard. pCRP 
is a 110 kDa pentamer with a pI at 6.4 and the pI changes to 5.6 upon 
monomerization[10]; both the molecular mass and the charge affect migration in this 
assay.  The pentameric form is less charged and larger and therefore does not run well 
into the gel. With GndHCl treatment, this band first shows up at 1.75M GndHCl and is 






Figure 31. Intrinsic fluorescence and native PAGE assays of CRP treated with GndHCl 
and Urea.  
Intrinsic, tryptophan fluorescence was measured by exciting solutions at 280 nm and 
recording fluorescence from 300-400 nm. The integrated fluorescence was normalized by 
the 0 M denaturant data point. Fluorescence decreased with increasing denaturants for 
both GndHCl (A) and Urea with EDTA (B). The dashed line in both represents the 
fluorescence intensity observed from an equivalent amount of free Trp.  Error bars are 
+/- SEM. C) Native PAGE of GndHCl treated CRP with two hours of incubation, D) 
Native PAGE of Urea:EDTA treated CRP with two hours of incubation. 
 
When pCRP is treated with Urea and EDTA, a clear transition exists in the gel 
from 2.25 to 4.0 M urea. The mCRP band increases over this range and the pCRP (not 
shown but retained in the stacking portion of the gel) disappears. A haze of protein is also 
observed in the gel and this fully disappears at 4.0M. This could be alternative states of 
pCRP that have not been fully characterized and these are present in the absence of Urea 




because urea is a weaker denaturant than GndHCl. Interestingly, the observed transition 
with Trp fluorescence is gradual from 2 – 6 M urea, over a much wider range than that 
observed in the gel, suggesting that conformational changes are still occurring that affect 
the Trp environment, but these changes do no broadly influence the size or charge of the 
protein in a way that affects how it runs on a gel. 
 
4.3.2 Hydrophobic portions of CRP are exposed 
To monitor CRP unfolding after incubation with different denaturants, 1-
Anilinonaphthalene-8-sulfonic Acid (ANS), a hydrophobic fluorescent probe was 
utilized. ANS is used frequently in biochemistry and biophysics research to study protein 
folding and aggregation. ANS binds to hydrophobic regions of proteins, which leads to a 
significant increase in quantum yield and a blue shift in the emission maxima[74], [77]. 
As shown in Figure 32, treatment with 2.5M GndHCl (Figure 31A), 3 or 6 M urea ( 
Figure 32B), or 0.01% SDS Figure 32C caused hydrophobic portions of CRP to be 
exposed. SDS-treated CRP showed the biggest change Figure 32 C, black circles from 
the untreated CRP (solid line in all figures). This means that more hydrophobic regions 
were exposed to ANS, and we suggested that this modified form of CRP (mCRP) mimics 
the physiological form of mCRP and maintain CRP function with downstream bindingTB 
partners as shown by another experiments performed in our lab. 
Our data revealed an increase in ANS fluorescence intensity with a high degree of 
blue shift when CRP was treated with 2.5M of GndHCl or 3M of Urea-EDTA. This could 
be due to an increase in the degree of hydrophobicity which leads to a strong binding 




GndHCl and 6M of Urea-EDTA caused a decrease in ANS fluorescence intensity with 
low degree of blue shift Figure 32. At high concentration of GndHCl, ANS still retains 
high fluorescence. If a protein is completely unfolded, ANS does not bind. This agrees 
with Figure Figure 31A where Trp fluorescence remains despite high concentrations of 
GndHCl. Both demonstrate that CRP retains structure in high concentration of 
denaturant. CRP exposed to BME and heat showed less binding to ANS and less degree 
in blue shift Figure 32C as compared with CRP that treated with SDS. This reduce in 
ANS fluorescence could be attributed to the reducing effect of BME which disrupts the 
disulfide bond in the protein and leads to protein aggregation.  
 
 
Figure 32. Treatment of pCRP with denaturants increase binding of 1-
Anilinonaphthalene-8-sulphonic acid (ANS). 
 A) ANS fluorescence upon binding to pCRP incubated with 2.5 M GndHCl (filled 
circles) or 3.0 M GndHCl (open circles) for 2 hours at 37°C. B) ANS fluorescence upon 
binding to pCRP incubated with 3 M (open circles) and 6 M (filled circles) Urea-EDTA 
at 37°C for 2 hours. C)  ANS fluorescence upon binding to pCRP that was incubated with 
0.01% SDS and BME then heated at 100°C for one hour (open circles) or 0.01% SDS 
then heated at 80°C for one hour (filled circles). In all figures, ANS fluorescence when 











4.4.4 SDS induced changes specifically increase C1q binding 
In our lab we compared a variety of methods for synthesizing mCRP from serum 
purified pCRP, which were tested for the ability to produce a form that binds C1q, one 
downstream binding partner of CRP in the complement immune response. One of the 
methods for altering the conformation of pCRP is with 0.01% SDS and heat. ELISA 
experiments, performed by Carrie Moon, with C1q or BSA used to capture CRP were 
used to compare binding of different CRPs. A polyclonal antibody to CRP with a biotin 
linkage was used to then bind horseradish peroxidase linked streptavidin (HRP-Strep). In 
Error! Reference source not found., the SDS treated CRP (blue) clearly shows 
significant binding to C1q as compared with pCRP (purple), or the antibody (green). The 
significant difference between mCRP and pCRP was confirmed with a Student’s t-test p 
value of 0.0071 (unpaired, two-tailed). pCRP binding to C1q is similar to the antibody 
(green) which indicates that pCRP does not bind C1q measurably. When BSA is used as 
a capture, pCRP shows no significant binding (orange) as compared with C1q captures 
for pCRP (blue). BSA captures slightly more 0.01% SDS and heat treated CRP than 
pCRP (pink) or antibodies (yellow), but mCRP with C1q as a capture (blue) still shows 
the strongest binding. This data indicates that CRP treated with 0.01% SDS in 80°C for 
an hour produces a modified form that is biologically relevant to mCRP observed in vivo 
due to C1q binding. This agrees with the work of Wang et al[21], where fluorescence 




























Figure 33. Dilute SDS treated CRP binds C1q in an ELISA assay. 
C1q or BSA was used as a capture agent for CRP. C1q captures CRP treated with 0.01% 
SDS and heated at 80°C for 1 hour (blue), but not pCRP (purple) or antibodies (green). 
BSA captures CRP significantly less than C1q (orange), but captures more 0.01% SDS: 
heat treated CRP than pCRP (pink) or antibodies (yellow). Error bars are +/- SEM and 
significance between mCRP and pCRP with C1q capture using an unpaired, two-tailed t-






















In this work, we compared the unfolding of CRP using different chemical 
denaturants. We used Urea/EDTA, guanidine HCl, and 0.01% SDS with heat to perturb 
the pentameric state. All treatments give rise to a monomeric state in native PAGE 
experiments, but only dilute SDS with heat treatments maintain CRP function with 
downstream binding partners. Biological activity of the monomeric state was tested by a 
binding assay with C1q, a downstream binding partner of mCRP. This is consistent with 






















CHAPTER FIVE: SUMMARY 
 
In this work, CRP binding and conversion was characterized as a function of 
membrane shape and chemical composition using a supported lipid bilayer biosensor that 
mimics the cell membrane. Despite knowing that the modified form of CRP, mCRP, 
binds downstream partners proteins better than the soluble form, pCRP, little is known 
about how these conformations affects CRP membrane interactions. The design of the 
biosensor permits to separately tune the lipids compositions and membrane shape. The 
primary component of lipids was POPC with and without lysoPC to mimic damaged 
membranes. The shape of membrane and curvature was controlled by using fluorescence 
nanoparticles with diameters (45 nm, 100 nm). Using this model system combined with 
quantitative fluorescence microscopy methods, CRP binding to lipid membranes was 
measured as a function of different conformations of CRP.  The monomeric form of CRP 
bound curved membranes, but the pentameric form did not until membranes became 
highly curved (radius = 27 nm). Unlike most other curvature sensing proteins, mCRP 
accumulated at a higher density in lower curvatures. The presence of lysoPC increased 
binding of CRP to all membranes. Overall, our results show that the protein form, lipid 
composition, and membrane shape affect CRP interactions differently and the mechanism 
by which CRP recognizes damaged membranes depends on the combination of all three. 
CRP interactions with cellular membranes was also investigated in this work 




SA cells. Apoptosis was confirmed using Annexin V, a protein binds to 
phosphatidylserine that exposed to the outer leaflet of the plasma membrane during the 
apoptosis. The data showed that CRP binds to the membrane of apoptotic cells more than 
the control cells.   
Disassociation of CRP on the membrane of the apoptotic cells was then monitored 
by using a RNA-aptamer that binds specifically to mCRP. Cells incubated for two hours 
with mCRP bound aptamer significantly more than cells incubated for an hour. CRP 
incubated with apoptotic cells for two hours significantly bound aptamer more than CRP 
incubated for an hour. These results suggested that during two hours of incubation more 
pCRP disassociates to mCRP.  
Unfolding of CRP was also characterized in this work using different chemical 
denaturants. Urea/EDTA, guanidine HCl, 0.01% SDS, and heat were used to perturb the 
pentameric state. All treatments give rise to a monomeric state in native PAGE 
experiments. The change in conformation was also assessed by tryptophan and ANS 
fluorescence. ANS binds to hydrophobic regions of proteins, which leads to a significant 
increase in quantum yield and a blue shift in the emission maxima. ANS fluorescence 
intensity increased when CRP treated with 2.5M Gnd-HCl, and with 3M urea-EDTA 
suggested that more hydrophobic regions were exposed and bound to ANS. The effect of 
different pH on CRP conformation was also assessed using ANS.  
This work could lead to a more specific diagnostic test for CVD risk based on 
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S 1. Native PAGE of pCRP, mCRP in HEPES, and PIPES buffer.  
a- Ladder. b,c- 50ug/ml of pCRP in HEPES, and PIPES respectively. d,e- 
40ug/ml of pCRP in HEPES, and PIPES respectively. f- 30ug/ml of pCRP in 
PIPES. g,i- mCRP made by heating pCRP with 0.01%SDS at 80c for an hour 
and left overnight before loaded to gel. h, and j- fresh mCRP. 
 
 
       S 2. Dot blot of primary anti- C-reactive protein (C6), mouse IgG monoclonal- 
















 S 3. Dot blot of primary anti- C-reactive protein (D7), mouse IgG monoclonal-antibody, 
and secondary goat anti mouse immunoglobulin G with Alexa 488.This has been done 





    Disassociation constant for the interaction of CRP with different ligands as determined 
by surface plasmon resonance      



















Matlab Codes used for these experiments 
CALCCORF CODE by Dr. Michelle Knowles 
function out=calccorf (red, green) 
 
% CALL: out=calccorf(red, green); 
%  
% PURPOSE:  to measure the Pearson's correlation coefficient between pairs of cropped 
images. 
% INPUT: 
% red: a ministack of croppped images that are stable in time (red NPs, 
% granules, clathrin pits, etc) 
% green: a ministack of cropped images that are more variable (syx, 
% proteins) - this is the channel that intensity is measured for.  
 
nredrows = length(red(1,1,:)); 
ngrnrows = length(green(1,1,:)); 
nrows = min(nredrows, ngrnrows); 
     
msk = zeros([1,2]); 
 
for i = 1:nrows; 
    g = green(:,:,i); 
    r = red(:,:,i); 
    normg = double(g)/double(max(max(g))); 
    normr = double(r)/double(max(max(r))); 
% calculate the Pearson's correlation coefficent (code from Taraska). 
    msk (i,1) = corr2(normr, normg); 
% remove saturated images DOES NOT WORK 
%    if max(max(g)) OR max(max(r)) = 4095 then 
%        msk (i, 2) = NaN 











RUN_MINISTK CODE modified by Mitch Alton 
function [] = run_ministk ( ) 
 
%ask for red and green channels 
[redfile,redpth] = uigetfile('*.tif','Select the Red Channel'); 
[grnfile,grnpth] = uigetfile('*.tif','Select the Green Channel'); 
 
%ask where to save the resulting file 
[savefile,savepth] = uiputfile('*.mat','Where to save the Results'); 
 




%view the image, imagesc autoscales. 
colormap('gray'),imagesc(a); 
 
% filter the image, 9 is a size, filter things larger than 9 pixels, and filter 1 or smaller 
b=bpass(a, 1, 9); 
colormap('gray'),imagesc(b); 
colormap('gray'),image(b);   
%seems to make a saturated mask like image when using beads 
 
%use the filtered image to find regions. 1500 is the threshold and 9 is a size of feature  
%you are looking for. Should be the same as above. RECORD THESE NUMBERS IN  
%YOUR NOTEBOOK! 
pk=pkfnd(b, 100, 9); 
 
%find centroids -  NOT NEEDED for colocalization routine 
cnt=cntrd(b, pk, 15); 
 




plot(pk(:,1), pk(:,2), 'ro'); 
zoom 
 
%once you like the threshold and want to cut out ministacks 
%do this with both color channels so that you can check it.  
cutout_red = ministk(a, pk, 24, 9); 
cutout_grn = ministk(c, pk, 24, 9); 
 




%is the size of images you will cut out and if spots are too close (within 9 pixels of one  
%another) you will not count either of them.  
 




cutout_red_avg = uint16(mean(cutout_red,3)); 





%see what regions were kept and save them. You do NOT need to do this with both  
%image files, since the spot locations will be identical. 
finalspt = keptspot(a, pk, 24, 9); 
save(fullfile(savepth,savefile)); 
 




plot(finalspt(:,1), finalspt(:,2), 'ro'); 
zoom 
 
%% Make a radial plot of pixel intensity 










%creates matrix of repeating columns of 1 through how ever many columns 

















%creates a matrix of intensities from image 
[THETA,RHO,Z]=cart2pol(x,y,z); 
 




%turns matrix into a list of values 
[t,I,J] = unique(RHO); 
s = zeros(size(t)); 
frequencies = zeros(size(t)); 
for i = 1:max(J) 
    I = find(J==i); 
    s(i) = mean(Z(I)); 




% Save the files 
radialPlot = cat(2,t,s); 
hgexport(gcf, fullfile(grnpth,[savefile '-grn-radial.png']), hgexport('factorystyle'), 
'Format', 'png'); 










%creates matrix of repeating columns of 1 through however many columns 

















%creates a matrix of intensities from image 
[THETA,RHO,Z]=cart2pol(x,y,z); 
 




%turns matrix into a list of values 
[t,I,J] = unique(RHO); 
s = zeros(size(t)); 
frequencies = zeros(size(t)); 
for i = 1:max(J) 
    I = find(J==i); 
    s(i) = mean(Z(I)); 




% Save the files 
radialPlot = cat(2,t,s); 
hgexport(gcf, fullfile(grnpth,[savefile '-red-radial.png']), hgexport('factorystyle'), 
'Format', 'png'); 













% PURPOSE:  to cut out small regions of an image based on spots found in 
% the image or a corresponding image of a different color. This is used to 
% measure colocalization based on the work of Knowles and Barg in two PNAS 
% 2011 papers. Spots are found using the work of tracking routines 
% available on Eric Weeks' website (Emory University) and made into Matlab 
% by Eric Dufrense. 
% INPUT: 
% im: image to cut from 
% rgn: spots (x,y) about which regions should be cut 
% sz: size of cut out (a square of sz by sz pixels) 
% sepdist: is the minimum separation distance between two spots. If two 
% spots are within this distance of one another, neither are counted. 
% 
% OUTPUT:  a sz x sz x N image array 
%            
% CREATED: Michelle Knowles May 2012 
 
%if sz/2 == floor(sz/2) 
%warning('sz must be even so that the spots can be centered on a pixel: 1 pixel added'); 
%sz = sz+1 
%end 
 
%scott's code for a mask 
pix=(sz+1)/2; 
dim = length(im); 
nrgn = length(rgn(:,1)); 
 
 
%create a blank image array that you can fill 
msk=zeros([sz+1,sz+1]); 
%loop through all regions that locate spots in an image 
for i =1:nrgn; 
    x = rgn(i,1); 
    y = rgn(i,2); 
    %don't include regions within pix distance from the edge of the image. 
    if ((x>pix) & ((x+pix)<dim) & (y>pix) & ((y+pix)<dim)) 
        % don't include regions within "sepdist" pixels of another region 
        % calculate an array that contains the difference between the 




        diffy=rgn(:,2)-rgn(i,2); 
        diffx=rgn(:,1)-rgn(i,1); 
        mag=((diffx.*diffx)+(diffy.*diffy).^0.5); 
        % find all the locations in the magnitude array that are non-zero. 
        % This should remove the comparison between particle i and itself, 
        % which will always be zero.  
        w = find(mag); 
        mag = mag(w); 
        if (min(mag) > sepdist)   
          cutout = imcrop(im,[x-pix y-pix sz sz]); 
          msk = cat(3, msk, cutout); 
        end 









COLO_NORM CODE by Mitch Alton 
 
%better_colo plots intensities of a location guided average image as a  
%function of distance from the center of the image. The second hald of the 
%program finds the area under the peak of the radial intensity plot. It 
%does this by dividing by the mean of the data after  
%the third pixel.  
%Written by Mitch Alton on 7/15/15 
[m, n]=size(a); 
%finds size of the image 
x=[1:n]; 
l=repmat(x,n,1); 
%creates matrix of repeating columns of 1 through however many columns 





%creates matrix of repeating rows 
x=l-(((n-1)*0.5)+1); 
y=w-(((n-1)*0.5)+1); 
%makes matrixes -# to +#. Not sure how this will work with even numbers 
%though 
z=a(1:m,1:n); 
%creates a matrix of intensities from image 
[THETA,RHO,Z]=cart2pol(x,y,z); 
%converts three matrixes to a three dimentional polar coordinate matrix 
G=reshape(z,1,(m*n)); 
H=reshape(RHO,1,(m*n)); 
%turns matrix into a list of values 
[t,I,J] = unique(H); 
s = zeros(size(t)); 
frequencies = zeros(size(t)); 
for i = 1:max(J) 
    I = find(J==i); 
    s(i) = mean(G(I)); 
    frequencies(i) = length(I); 
end 
%this averages the intensities (Z) for single distance (RHO) values 
ydatatemp=s(:,8:83); 
%limits the yvalues to just the values past 3 pixels from the center of the 













%this gives a number for the area of the peak from the colocalization 










































SPOTTEST CODE by Dr. Philip Cheney 
%spottest -- Load, look for spots, show a picture 
%   
% this program is used to determine the properties of a movie or image 
% containing spots.  
% 
% INPUT: 
%   movieOrImage is a movie or image containing spots  
% 
% 
% PC 24 Apr 2014 
% 
% This is converted from the old spot check functions, so there may be 
% unused cruft still hanging around in here. 
 
figure; 
movieOrImageLoaded = loadSingleTIFF(movieOrImage); 









    figure; 
    sawSpots = seeingSpotsAml(movieOrImageLoaded,sawSpots.numberFrames); 
    
imshow(movieOrImageLoaded(:,:,sawSpots.numberFrames),[min(movieOrImageLoaded
(:)) max(movieOrImageLoaded(:))*0.5]); 
    hold on; 
    plot(sawSpots.spotsDetected(:,1,1),sawSpots.spotsDetected(:,2,1),'ro','MarkerSize',20); 
    title(['Frame ',num2str(sawSpots.numberFrames)]); 
end 
 
